{
  "ctx_json": {
    "main": "ATXN3",
    "interactors": [
      {
        "primary": "VCP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with VCP/p97, an AAA+ ATPase involved in protein quality control, via a VCP binding motif (VBM) on ATXN3. This interaction is crucial for processes like ER-associated degradation (ERAD).",
        "functions": [
          {
            "function": "ER-Associated Degradation (ERAD)",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 binds to VCP/p97 via its VCP-binding motif (VBM) and competes with other VCP cofactors like Ufd1. This interaction modulates the extraction of ubiquitinated substrates from the endoplasmic reticulum.",
            "effect_description": "By binding to VCP, ATXN3 reduces the retrotranslocation of misfolded proteins from the ER to the cytosol for proteasomal degradation, thereby acting as a negative regulator of the ERAD pathway's flow.",
            "biological_consequence": [
              "ATXN3 binding to VCP → Sequesters VCP from other cofactors (e.g., Ufd1/Npl4) → Decreased extraction of ERAD substrates → Accumulation of misfolded proteins in the ER → ER stress"
            ],
            "specific_effects": [
              "ATXN3 and Ufd1 bind to VCP in a mutually exclusive manner.",
              "ATXN3 decreases the interaction of VCP with ubiquitylated proteins.",
              "Pathological polyQ expansion in ATXN3 enhances VCP binding, leading to greater impairment of ERAD."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
                "year": 2006
              },
              {
                "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 couples pulldown and deubiquitylation of ubiquitylated proteins",
                "year": 2020
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Lysosome Regeneration",
            "arrow": "activates",
            "cellular_process": "Following lysosomal membrane damage, ATXN3 and its partner VCP/p97 are recruited to a subset of recovering lysosomes. There, they target and process K48-K63-branched ubiquitin chains on lysosomal proteins, such as LAMP2.",
            "effect_description": "This processing facilitates the degradation of a fraction of LAMP2 via microautophagy, which helps to regenerate the lysosomal membrane and restore the overall degradative capacity of the lysosomal system.",
            "biological_consequence": [
              "Lysosomal damage → ATXN3/VCP recruitment → Processing of branched ubiquitin chains on LAMP2 → LAMP2 degradation via microautophagy → Lysosomal membrane regeneration → Restoration of cellular degradative capacity"
            ],
            "specific_effects": [
              "ATXN3 is required for lysophagic flux after lysosomal damage but not for the initial phagophore formation.",
              "The ATXN3-VCP complex specifically targets K48-K63-branched ubiquitin conjugates on regenerating lysosomes."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
                "year": 2025
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "PI3K Complex Assembly and Activity",
            "arrow": "activates",
            "cellular_process": "VCP/p97 interacts with components of the class III PI3K complex, including BECN1 and ATG14. VCP stimulates the deubiquitinase activity of ATXN3, which in turn stabilizes BECN1.",
            "effect_description": "By promoting the stabilization of BECN1 and the assembly of the PI3K complex, VCP enhances the production of phosphatidylinositol-3-phosphate (PtdIns3P), a critical step for initiating autophagosome formation.",
            "biological_consequence": [
              "VCP activates ATXN3 DUB activity → ATXN3 stabilizes BECN1 → VCP promotes PI3K complex assembly → Increased PtdIns3P production → Recruitment of early autophagy markers (WIPI2, ATG16L1) → Autophagy initiation"
            ],
            "specific_effects": [
              "VCP's role in autophagy initiation is in addition to its known role in autophagosome maturation.",
              "Acute inhibition of VCP impairs PtdIns3P production and the recruitment of early autophagy machinery."
            ],
            "evidence": [
              {
                "paper_title": "VCP/p97 modulates PtdIns3P production and autophagy initiation",
                "year": 2021
              },
              {
                "paper_title": "New functions of a known autophagy regulator: VCP and autophagy initiation",
                "year": 2021
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "regulates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates",
            "inhibits"
          ]
        }
      },
      {
        "primary": "PARK2",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and deubiquitinates the E3 ubiquitin ligase Parkin (PARK2), thereby regulating its activity. This interaction is implicated in pathways related to both protein degradation and neurodegenerative diseases like Parkinson's.",
        "functions": [
          {
            "function": "Parkin Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "PolyQ-expanded ATXN3 enhances the deubiquitination of Parkin, with a preference for cleaving K27- and K29-linked ubiquitin chains that may protect Parkin from autophagic degradation.",
            "effect_description": "By preferentially removing these protective ubiquitin chains, mutant ATXN3 promotes the autophagic degradation of Parkin, leading to reduced Parkin levels. This gain of toxic function may contribute to parkinsonian features in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 deubiquitinates PARK2 (cleaves K27/K29 chains) → Increased PARK2 turnover → Enhanced autophagic degradation of PARK2 → Reduced PARK2 protein levels → Impaired mitophagy and mitochondrial quality control"
            ],
            "specific_effects": [
              "This effect is specific to polyQ-expanded ATXN3 and leads to a reduction of Parkin levels in MJD mouse models.",
              "The loss of Parkin function is a primary cause of familial Parkinson's disease."
            ],
            "evidence": [
              {
                "paper_title": "Mutant ataxin-3 promotes the autophagic degradation of parkin",
                "year": 2011
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "HDAC6",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly binds to Histone Deacetylase 6 (HDAC6). This interaction is involved in the cellular machinery that sorts protein aggregates to the aggresome via microtubules.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with HDAC6, a key component of the machinery that transports misfolded protein aggregates to the aggresome. ATXN3's DUB activity generates unanchored ubiquitin C-termini on aggregates, which are then recognized by the ubiquitin-binding domain of HDAC6.",
            "effect_description": "This interaction facilitates the recruitment of misfolded protein aggregates to the dynein motor complex for retrograde transport along microtubules to the perinuclear aggresome.",
            "biological_consequence": [
              "ATXN3 trims ubiquitin chains on aggregates → Exposes ubiquitin C-termini → HDAC6 binds exposed C-termini → HDAC6 links aggregate to Dynein motor → Transport to aggresome"
            ],
            "specific_effects": [
              "ATXN3, HDAC6, and dynein are part of a complex that has ubiquitin protease activity.",
              "Depletion of ATXN3 leads to decreased aggresome formation.",
              "HDAC6 recognizes and binds to unanchored C-terminal diglycine motifs of ubiquitin generated by ATXN3 on protein aggregates."
            ],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              },
              {
                "paper_title": "Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini",
                "year": 2012
              },
              {
                "paper_title": "The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Actin-Dependent Cell Motility",
            "arrow": "activates",
            "cellular_process": "ATXN3 stabilizes HDAC6, which in turn deacetylates the F-actin-binding protein cortactin. The acetylation status of cortactin modulates its ability to bind F-actin.",
            "effect_description": "By increasing HDAC6 levels, ATXN3 indirectly promotes the deacetylation of cortactin, which alters actin cytoskeleton dynamics and enhances cell motility.",
            "biological_consequence": [
              "ATXN3 stabilizes HDAC6 → Increased HDAC6 activity → Deacetylation of cortactin → Altered cortactin-F-actin binding → Modulation of actin cytoskeleton → Enhanced cell motility"
            ],
            "specific_effects": [
              "HDAC6 influences actin-dependent cell motility in addition to its role in microtubule-dependent transport."
            ],
            "evidence": [
              {
                "paper_title": "HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "RAD23A",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the proteasome-associated protein RAD23A (hHR23A), which is involved in delivering ubiquitinated substrates to the proteasome and also prevents the proteasomal degradation of ATXN3 itself.",
        "functions": [
          {
            "function": "Proteasome-Mediated Protein Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with RAD23A (hHR23A), a shuttle protein that delivers ubiquitinated substrates to the 26S proteasome for degradation.",
            "effect_description": "This interaction links ATXN3 to the proteasomal degradation pathway, potentially influencing the fate of ubiquitinated proteins by either promoting their delivery to the proteasome or deubiquitinating them prior to degradation.",
            "biological_consequence": [
              "ATXN3 binds RAD23A → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome"
            ],
            "specific_effects": [
              "ATXN3's interaction with Rad23 homologs suggests it can monitor proteasome traffic and the delivery of ubiquitylated proteins.",
              "The interaction between ATXN3 and RAD23A has been confirmed by co-immunoprecipitation."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A",
                "year": 1999
              },
              {
                "paper_title": "Physiological and pathophysiological characteristics of ataxin-3 isoforms",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "RAD23B",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which plays a similar role in the ubiquitin-proteasome system and in protecting ATXN3 from degradation.",
        "functions": [
          {
            "function": "Proteasome-Mediated Protein Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which functions as a shuttle protein to deliver ubiquitinated substrates to the 26S proteasome.",
            "effect_description": "This interaction connects ATXN3 to the ubiquitin-proteasome system, where it can influence the processing of substrates destined for degradation.",
            "biological_consequence": [
              "ATXN3 binds RAD23B → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome"
            ],
            "specific_effects": [
              "ATXN3's interaction with Rad23 homologs is implicated in its role in ERAD.",
              "The interaction between ATXN3 and RAD23B has been confirmed by co-immunoprecipitation."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A",
                "year": 1999
              },
              {
                "paper_title": "Physiological and pathophysiological characteristics of ataxin-3 isoforms",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "STUB1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with and deubiquitinates STUB1 (CHIP), an E3 ubiquitin ligase, thereby modulating its activity within the ubiquitin-proteasome system.",
        "functions": [
          {
            "function": "Chaperone-Mediated Substrate Degradation",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 collaborates with the E3 ligase STUB1/CHIP and chaperones (e.g., HSP70) in the degradation of misfolded substrates via pathways like chaperone-mediated autophagy (CMA) and the proteasome.",
            "effect_description": "ATXN3 modulates this process by trimming the length of ubiquitin chains that CHIP adds to substrates. This editing function can alter the fate of the substrate, preventing excessive ubiquitination and potentially diverting it from immediate degradation.",
            "biological_consequence": [
              "Misfolded substrate binds HSP70/CHIP complex → CHIP ubiquitinates substrate → ATXN3 trims polyubiquitin chains → Modulated signal for degradation (proteasome or CMA) → Altered substrate turnover"
            ],
            "specific_effects": [
              "STUB1/CHIP is required for the CMA-mediated degradation of substrates like HIF1A.",
              "ATXN3 restricts the length of ubiquitin chains attached to STUB1/CHIP substrates, preventing further chain extension."
            ],
            "evidence": [
              {
                "paper_title": "STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy",
                "year": 2013
              },
              {
                "paper_title": "Co-Chaperone HSJ1a Dually Regulates the Proteasomal Degradation of Ataxin-3",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "TP53",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly binds to and stabilizes the tumor suppressor p53 (TP53) by removing polyubiquitin chains, thereby preventing its degradation and promoting p53-mediated signaling.",
        "functions": [
          {
            "function": "TP53 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a deubiquitinase for the tumor suppressor p53 (TP53). It binds directly to both native and polyubiquitinated p53 and removes ubiquitin chains, protecting it from proteasomal degradation.",
            "effect_description": "By stabilizing p53, ATXN3 enhances its transcriptional activity and promotes p53-mediated cellular responses like apoptosis and cell cycle arrest.",
            "biological_consequence": [
              "ATXN3 deubiquitinates TP53 → TP53 protein stabilization → Increased TP53 transcriptional activity → Enhanced p53-dependent apoptosis and cell cycle arrest."
            ],
            "specific_effects": [
              "ATXN3 deletion destabilizes p53, leading to reduced p53 activity.",
              "ATXN3 stabilizes p53 via the ubiquitin-proteasome pathway, not the lysosomal pathway.",
              "PolyQ-expanded ATXN3 has an enhanced ability to bind and deubiquitinate p53, leading to prolonged p53 signaling and increased apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53",
                "year": 2015
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "PNKP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 forms a direct complex with Polynucleotide Kinase 3'-Phosphatase (PNKP) to promote its phosphatase activity, playing a role in DNA single-strand break repair.",
        "functions": [
          {
            "function": "DNA Strand Break Repair",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 forms a complex with Polynucleotide Kinase 3'-Phosphatase (PNKP), a key enzyme in the repair of DNA single- and double-strand breaks. This interaction promotes PNKP's 3'-phosphatase activity.",
            "effect_description": "By enhancing PNKP's enzymatic activity, ATXN3 facilitates the efficient repair of DNA strand breaks, thereby maintaining genome integrity.",
            "biological_consequence": [
              "ATXN3 binds PNKP → Promotes PNKP phosphatase activity → Efficient processing of 3'-phosphate termini at DNA breaks → Facilitates DNA single-strand and double-strand break repair."
            ],
            "specific_effects": [
              "PNKP is a dual-function enzyme involved in single-strand break repair and nonhomologous end joining.",
              "Mutant, polyQ-expanded ATXN3 inhibits PNKP activity, leading to the accumulation of DNA damage."
            ],
            "evidence": [
              {
                "paper_title": "Wild-type Ataxin-3 promotes error-free DNA repair and maintains genome stability, whereas the mutant form compromises this function",
                "year": 2015
              },
              {
                "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
                "year": 2015
              },
              {
                "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "MDC1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "As a deubiquitinase, ATXN3 directly counteracts the polyubiquitination of Mediator Of DNA Damage Checkpoint 1 (MDC1), prolonging its presence on chromatin and ensuring proper DNA damage response activation.",
        "functions": [
          {
            "function": "DNA Damage Response Signaling",
            "arrow": "activates",
            "cellular_process": "In the early phase of the DNA double-strand break (DSB) response, ATXN3 acts as a deubiquitinase for the checkpoint mediator MDC1. It counteracts the activity of the SUMO-targeted ubiquitin ligase RNF4, which promotes MDC1's removal from chromatin.",
            "effect_description": "By deubiquitinating MDC1, ATXN3 prevents its premature removal from DNA lesions, prolonging its chromatin dwell time and ensuring a robust and consolidated activation of the downstream DNA damage response cascade.",
            "biological_consequence": [
              "ATXN3 counteracts RNF4-mediated MDC1 ubiquitination → Increased MDC1 residence time at DSBs → Efficient recruitment of downstream factors (RNF8, RNF168, BRCA1, 53BP1) → Robust DNA repair signaling."
            ],
            "specific_effects": [
              "Loss of ATXN3 reduces the chromatin dwell time of MDC1 at DSBs.",
              "ATXN3 is required for efficient MDC1-dependent DSB repair by both non-homologous end-joining and homologous recombination.",
              "ATXN3 is recruited to DSBs in a SUMOylation-dependent manner."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
                "year": 2017
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "CHEK1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with Checkpoint Kinase 1 (CHEK1) and prevents its polyubiquitination and subsequent degradation, which is important for facilitating DNA damage checkpoints and repair.",
        "functions": [
          {
            "function": "DNA Damage Checkpoint Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with the checkpoint kinase Chk1 and protects it from polyubiquitination and subsequent proteasomal degradation mediated by E3 ligases like DDB1/CUL4A and FBXO6/CUL1.",
            "effect_description": "By deubiquitinating and stabilizing Chk1, ATXN3 maintains the steady-state levels of Chk1, which is essential for proper activation of DNA damage checkpoints (e.g., G2/M checkpoint) and facilitating DNA repair.",
            "biological_consequence": [
              "ATXN3 deubiquitinates CHEK1 → CHEK1 protein stabilization → Maintenance of CHEK1 levels → Proper G2/M checkpoint arrest upon DNA damage → Genome integrity."
            ],
            "specific_effects": [
              "ATXN3 deficiency leads to a pronounced reduction of Chk1 levels and compromises the G2/M checkpoint.",
              "Under prolonged replication stress, Chk1 is phosphorylated and dissociates from ATXN3, allowing for its degradation and checkpoint termination."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 promotes genome integrity by stabilizing Chk1",
                "year": 2017
              },
              {
                "paper_title": "Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint",
                "year": 2000
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "BECN1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly deubiquitinates Beclin 1 (BECN1), a key protein in autophagy, leading to its stabilization and the stimulation of the autophagic process.",
        "functions": [
          {
            "function": "Apoptosis/Autophagy Checkpoint",
            "arrow": "activates",
            "cellular_process": "BECN1 is a key protein that integrates apoptosis and autophagy signaling, partly through its inhibitory interaction with the anti-apoptotic protein Bcl-2 at the endoplasmic reticulum.",
            "effect_description": "By deubiquitinating and stabilizing BECN1, ATXN3 increases the total pool of BECN1 available to participate in cellular signaling. This can influence the threshold for inducing either autophagy (when BECN1 is released from Bcl-2) or apoptosis, thus modulating the cell's life/death decision.",
            "biological_consequence": [
              "ATXN3 stabilizes BECN1 → Increased BECN1 protein pool → Modulates the equilibrium of the BECN1-Bcl-2 complex → Influences the switch between autophagy and apoptosis"
            ],
            "specific_effects": [
              "The interaction between Bcl-2 and BECN1 inhibits autophagy.",
              "Disruption of the Bcl-2/BECN1 complex is a key step in autophagy induction.",
              "Caspase-mediated cleavage of BECN1 can generate fragments that promote apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch",
                "year": 2013
              },
              {
                "paper_title": "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy",
                "year": 2005
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "YAP1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 functions as a deubiquitinase for Yes-associated protein 1 (YAP1), removing polyubiquitin chains to protect it from degradation and thereby promoting its oncogenic activity.",
        "functions": [
          {
            "function": "YAP1 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with, deubiquitinates, and stabilizes the Hippo pathway effector YAP1. By removing K48-linked polyubiquitin chains, ATXN3 prevents the proteasomal degradation of YAP1.",
            "effect_description": "This stabilization increases the overall protein levels of YAP1, allowing it to translocate to the nucleus and activate the transcription of its target genes, which are involved in cell proliferation and migration.",
            "biological_consequence": [
              "ATXN3 deubiquitinates YAP1 → Reduced YAP1 degradation → Increased YAP1 protein levels → Enhanced nuclear translocation and transcriptional activity → Upregulation of target genes (CTGF, CYR61) → Promotion of cancer cell proliferation and migration"
            ],
            "specific_effects": [
              "ATXN3 depletion decreases YAP1 protein levels and the expression of YAP/TEAD target genes.",
              "The Josephin domain of ATXN3 interacts with the WW domain of YAP.",
              "ATXN3 specifically inhibits K48-linked polyubiquitination of YAP1.",
              "The interaction and subsequent stabilization of YAP1 by ATXN3 is observed in multiple cancer types, including breast, pancreatic, and prostate cancer."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 deubiquitinates YAP1 to promote tumor growth",
                "year": 2021
              },
              {
                "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
                "year": 2023
              },
              {
                "paper_title": "The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "HDAC3",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 cooperates with and directly regulates the ubiquitination state of Histone Deacetylase 3 (HDAC3), implicating it in transcriptional regulation and immune responses.",
        "functions": [
          {
            "function": "HDAC3 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with and deubiquitinates Histone Deacetylase 3 (HDAC3), protecting it from proteasomal degradation.",
            "effect_description": "By stabilizing HDAC3, ATXN3 enhances its protein levels, which is crucial for modulating cellular processes like the type I interferon (IFN-I) antiviral response.",
            "biological_consequence": [
              "ATXN3 deubiquitinates HDAC3 → Increased HDAC3 protein stability → Enhanced IFN-I signaling pathway → Potentiated antiviral response"
            ],
            "specific_effects": [
              "ATXN3 deubiquitinates both K48- and K63-linked ubiquitin chains on HDAC3.",
              "The interaction between ATXN3 and HDAC3 increases during viral infection.",
              "Overexpression of ATXN3 upregulates HDAC3 protein levels, while ATXN3 knockout down-regulates them."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
                "year": 2018
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 recruits HDAC3 to specific gene promoters, such as the MMP-2 promoter, leading to histone deacetylation and transcriptional repression.",
            "effect_description": "This interaction forms a repressor complex that silences gene expression. ATXN3's role in this context is to facilitate the enzymatic activity of HDAC3 on chromatin.",
            "biological_consequence": [
              "ATXN3 binds target promoter → Recruits HDAC3/NCoR complex → Histone deacetylation at promoter → Chromatin condensation → Repression of gene transcription (e.g., MMP-2)"
            ],
            "specific_effects": [
              "Normal ATXN3 cooperates with HDAC3 to repress transcription, a function requiring its ubiquitin-interacting motifs (UIMs).",
              "PolyQ-expanded ATXN3 fails to properly recruit HDAC3, leading to a loss of repressor function and aberrant gene expression.",
              "ATXN3 and HDAC3 cooperate to regulate chromatin organization, a function that is independent of ATXN3's catalytic activity."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "year": 2008
              },
              {
                "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
                "year": 2018
              },
              {
                "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "CREBBP",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is known to interact and cooperate with the transcriptional co-activator CREB-binding protein (CREBBP or CBP), suggesting a direct role in transcriptional regulation.",
        "functions": [
          {
            "function": "CREBBP/p300 Histone Acetyltransferase (HAT) Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly interacts with the transcriptional co-activators CREBBP (CBP) and EP300 (p300), which possess histone acetyltransferase (HAT) activity.",
            "effect_description": "Through this interaction, ATXN3 acts as a transcriptional repressor by inhibiting the HAT activity of the CBP/p300 complex, thereby preventing histone acetylation and gene activation.",
            "biological_consequence": [
              "ATXN3 binds to CREBBP/p300 → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression"
            ],
            "specific_effects": [
              "The C-terminal domain of ATXN3 binds to CREBBP and p300.",
              "ATXN3 is known to cooperate with numerous transcriptional regulators including CBP and p300 to control transcription."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "year": 2008
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "EP300",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the transcriptional co-activator p300 (EP300), indicating its involvement in the regulation of gene expression through chromatin modification.",
        "functions": [
          {
            "function": "CREBBP/p300 Histone Acetyltransferase (HAT) Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly interacts with the transcriptional co-activators EP300 (p300) and CREBBP (CBP), which possess histone acetyltransferase (HAT) activity.",
            "effect_description": "This interaction allows ATXN3 to function as a transcriptional repressor by inhibiting the HAT activity of the p300/CBP complex, which in turn prevents histone acetylation required for gene activation.",
            "biological_consequence": [
              "ATXN3 binds to EP300/CREBBP → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression"
            ],
            "specific_effects": [
              "The C-terminal domain of ATXN3 binds to p300 and CREBBP.",
              "ATXN3 is part of a network of transcriptional regulators that includes p300 and CBP."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "year": 2008
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "KEAP1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 regulates the stability of Kelch-like ECH-associated protein 1 (KEAP1) by slowing its proteasomal degradation, suggesting a direct deubiquitinase-substrate relationship.",
        "functions": [
          {
            "function": "KEAP1 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 regulates the turnover of KEAP1, a substrate adaptor for the CUL3 E3 ubiquitin ligase complex that targets NRF2 for degradation.",
            "effect_description": "ATXN3 promotes the stability of KEAP1 by slowing its degradation, thereby maintaining the repression of the NRF2-mediated antioxidant response under basal conditions.",
            "biological_consequence": [
              "ATXN3 stabilizes KEAP1 → Maintained KEAP1 levels → Constitutive ubiquitination and degradation of NRF2 → Repression of antioxidant gene expression"
            ],
            "specific_effects": [
              "Depletion of ATXN3 leads to destabilization and a decreased half-life of the KEAP1 protein.",
              "Loss of ATXN3 and the subsequent decrease in KEAP1 levels result in an increase of NRF2 and p62/SQSTM1."
            ],
            "evidence": [
              {
                "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
                "year": 2021
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "BCL2",
        "interaction_type": "indirect",
        "upstream_interactor": "PARK2",
        "mediator_chain": [
          "PARK2"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly regulates the autophagy inhibitor B-cell lymphoma 2 (BCL2) by modulating the E3 ligase activity of Parkin, which in turn ubiquitinates BCL2.",
        "functions": [
          {
            "function": "BCL2 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 modulates the E3 ligase activity of Parkin (PARK2). Functional PARK2 directly interacts with and mono-ubiquitinates the anti-apoptotic and autophagy-inhibitory protein BCL2.",
            "effect_description": "This mono-ubiquitination by PARK2 stabilizes BCL2 and increases its steady-state protein levels. By regulating PARK2, ATXN3 indirectly controls the stability of BCL2, a key regulator of apoptosis and autophagy.",
            "biological_consequence": [
              "ATXN3 regulates PARK2 activity → PARK2 mono-ubiquitinates BCL2 → Increased BCL2 protein stability → Enhanced inhibition of autophagy and apoptosis"
            ],
            "specific_effects": [
              "PARK2 directly binds to BCL2 and mediates its mono-ubiquitination.",
              "The mono-ubiquitination of BCL2 by PARK2 increases its protein level.",
              "By stabilizing BCL2, PARK2 enhances the interaction between BCL2 and the autophagy initiator Beclin 1, thereby inhibiting autophagy."
            ],
            "evidence": [
              {
                "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
                "year": 2010
              },
              {
                "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
                "year": 2012
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "PARK2",
              "chain": [
                "PARK2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "SOD2",
        "interaction_type": "indirect",
        "upstream_interactor": "FOXO4",
        "mediator_chain": [
          "FOXO4"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly regulates the expression of Superoxide Dismutase 2 (SOD2) by modulating the activity of the transcription factor FOXO4, which controls the antioxidant stress response.",
        "functions": [
          {
            "function": "SOD2 Gene Transcription",
            "arrow": "activates",
            "cellular_process": "ATXN3 functions as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, both ATXN3 and FOXO4 translocate to the nucleus, where they coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.",
            "effect_description": "By enhancing the FOXO4-dependent transcription of SOD2, ATXN3 indirectly boosts the expression of this critical mitochondrial antioxidant enzyme, which is essential for clearing superoxide radicals.",
            "biological_consequence": [
              "Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-activation of SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced scavenging of mitochondrial reactive oxygen species (ROS)"
            ],
            "specific_effects": [
              "The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.",
              "Knockdown of ATXN3 represses the expression of SOD2.",
              "Mutant ATXN3 has a reduced capacity to activate FOXO4-mediated SOD2 expression."
            ],
            "evidence": [
              {
                "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
                "year": 2011
              },
              {
                "paper_title": "Redox regulation of FoxO transcription factors",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "FOXO4",
              "chain": [
                "FOXO4"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "BAX",
        "interaction_type": "indirect",
        "upstream_interactor": "TP53",
        "mediator_chain": [
          "TP53"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly upregulates the mRNA expression of the pro-apoptotic protein BAX by enhancing the transcriptional activity of p53, which it directly stabilizes.",
        "functions": [
          {
            "function": "Apoptosis",
            "arrow": "activates",
            "cellular_process": "ATXN3 indirectly promotes the expression of the pro-apoptotic protein BAX. This occurs through the direct stabilization and activation of the transcription factor p53, which in turn transcriptionally upregulates its target gene, BAX.",
            "effect_description": "By increasing p53 stability, ATXN3 enhances the p53-mediated apoptotic pathway. PolyQ-expanded ATXN3 shows an even stronger ability to stabilize p53, leading to heightened p53-dependent apoptosis, which contributes to neurodegeneration.",
            "biological_consequence": [
              "ATXN3 stabilizes TP53 -> Increased TP53 transcriptional activity -> Upregulation of BAX mRNA expression -> Increased BAX protein levels -> Promotion of apoptosis"
            ],
            "specific_effects": [
              "p53 promotes neuronal apoptosis by enhancing the transcription of proapoptotic genes including Bax.",
              "Mutant ATXN3 increases p53 stability, leading to increased p53-dependent apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "Tissue-specific vulnerability to apoptosis in Machado-Joseph disease",
                "year": 2023
              },
              {
                "paper_title": "Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons",
                "year": 2010
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "TP53",
              "chain": [
                "TP53"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "FOXO4",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with the transcription factor FOXO4, and upon oxidative stress, they translocate to the nucleus together to activate the transcription of the SOD2 gene.",
        "functions": [
          {
            "function": "Antioxidant Gene Transcription",
            "arrow": "activates",
            "cellular_process": "Under conditions of oxidative stress, ATXN3 interacts with the transcription factor FOXO4. Both proteins translocate to the nucleus and coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.",
            "effect_description": "This co-activation enhances the FOXO4-dependent transcription of SOD2, a key antioxidant enzyme, thereby promoting cellular defense against reactive oxygen species (ROS).",
            "biological_consequence": [
              "Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-binding to SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced clearance of ROS → Cellular protection"
            ],
            "specific_effects": [
              "The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.",
              "Knockdown of ATXN3 represses the expression of SOD2.",
              "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression and interferes with FOXO4 binding to the SOD2 promoter."
            ],
            "evidence": [
              {
                "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
                "year": 2011
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "Redox regulation of FoxO transcription factors",
                "year": 2015
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "NRF2",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is thought to deubiquitinate and stabilize the transcription factor NRF2 (NFE2L2), a master regulator of the antioxidant response, which is a function analogous to other deubiquitinases like DUB3.",
        "functions": [
          {
            "function": "Antioxidant Response Activation",
            "arrow": "activates",
            "cellular_process": "ATXN3 is proposed to regulate the NRF2 pathway, which controls the expression of antioxidant and detoxification enzymes. This likely occurs through the deubiquitination and stabilization of NRF2, preventing its KEAP1-mediated degradation.",
            "effect_description": "By stabilizing NRF2, ATXN3 would promote its nuclear translocation and subsequent activation of Antioxidant Response Element (ARE)-containing genes, enhancing the cell's capacity to counteract oxidative stress.",
            "biological_consequence": [
              "ATXN3 deubiquitinates NRF2 → NRF2 escapes KEAP1-mediated degradation → NRF2 accumulates and translocates to nucleus → Binds to ARE sequences → Transcription of antioxidant genes (e.g., HO-1, NQO1)"
            ],
            "specific_effects": [
              "NRF2 is a master regulator of the antioxidant response, and its stability is tightly controlled by KEAP1-mediated ubiquitination.",
              "Activation of the NRF2 pathway is a key cellular defense against oxidative stress."
            ],
            "evidence": [
              {
                "paper_title": "The complexity of the Nrf2 pathway: Beyond the antioxidant response",
                "year": 2015
              },
              {
                "paper_title": "The effect of ATX through Nrf2 pathway on different disorders.",
                "year": 2023
              },
              {
                "paper_title": "Activation of NRF2 and FXN in Friedreich Ataxia",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "TRAF6",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is known to deubiquitinate TNF receptor-associated factor 6 (TRAF6), thereby modulating immune signaling pathways.",
        "functions": [
          {
            "function": "NF-κB and MAPK Signaling",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 acts as a deubiquitinase for TRAF6, an E3 ubiquitin ligase crucial for activating downstream signaling pathways like NF-κB and MAPK upon stimulation of receptors such as TLRs and TNFRs.",
            "effect_description": "By cleaving polyubiquitin chains from TRAF6, ATXN3 negatively regulates its signaling activity, thereby dampening the inflammatory response.",
            "biological_consequence": [
              "ATXN3 deubiquitinates TRAF6 → Reduced TRAF6-mediated signaling → Decreased activation of IKK complex and MAPKs → Attenuated NF-κB and AP-1 activation → Downregulation of inflammatory gene expression"
            ],
            "specific_effects": [],
            "evidence": [
              {
                "paper_title": "CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "LC3",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 contains conserved LIR domains that directly interact with the autophagy adaptors LC3C and GABARAP, localizing to early autophagosomes in a transient regulatory interaction.",
        "functions": [
          {
            "function": "Autophagosome Association",
            "arrow": "activates",
            "cellular_process": "ATXN3 contains LC3-interacting region (LIR) motifs that allow it to directly bind to members of the Atg8 protein family, such as LC3 and GABARAP, which are localized on autophagosomal membranes.",
            "effect_description": "This interaction recruits ATXN3 to autophagosomes, suggesting a role in regulating the autophagic process, potentially by deubiquitinating substrates at the site of degradation or influencing autophagosome maturation.",
            "biological_consequence": [
              "ATXN3 binds to LC3/GABARAP via LIR motif → Recruitment of ATXN3 to autophagosome membrane → Modulation of local ubiquitination events → Regulation of autophagic flux"
            ],
            "specific_effects": [
              "LIR motifs are short linear sequences that mediate binding to Atg8-family proteins.",
              "Proteins containing LIR motifs are recruited to LC3/GABARAP through hydrophobic interactions.",
              "UIM-containing proteins, including ATXN3, have been shown to interact with both LC3 and GABARAP subfamilies."
            ],
            "evidence": [
              {
                "paper_title": "Semisynthetic LC3 Probes for Autophagy Pathways Reveal a Noncanonical LC3 Interacting Region Motif Crucial for the Enzymatic Activity of Human ATG3",
                "year": 2020
              },
              {
                "paper_title": "The rapidly expanding role of LC3-interacting regions in autophagy",
                "year": 2024
              },
              {
                "paper_title": "Atg8-Family Proteins—Structural Features and Molecular Interactions in Autophagy and Beyond",
                "year": 2020
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "PML",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with the Promyelocytic leukemia (PML) protein, and expression of mutant ATXN3 alters the normal nuclear distribution of PML.",
        "functions": [
          {
            "function": "PML Nuclear Body Organization",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 interacts with the Promyelocytic leukemia (PML) protein, a key component of PML nuclear bodies, which are subnuclear structures involved in various cellular processes like transcription, DNA repair, and apoptosis.",
            "effect_description": "The expression of polyQ-expanded ATXN3 disrupts the normal structure and distribution of PML nuclear bodies, which may contribute to the transcriptional dysregulation and cellular stress seen in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 interacts with PML → Sequestration or mislocalization of PML protein → Disruption of PML nuclear body integrity → Impaired PML-dependent cellular functions"
            ],
            "specific_effects": [
              "Expression of certain PML isoforms (e.g., PML IV) can promote the degradation of soluble polyQ proteins, a protective mechanism that is disrupted when PML is mislocalized. [4]",
              "The sequestration of PML by mutant ATXN3 can impair the DNA damage response (DDR) and other PML-NB-associated functions. [7]"
            ],
            "evidence": [
              {
                "paper_title": "PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "SP1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 can act as a transcriptional co-repressor by interacting with the transcription factor SP1.",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "ATXN3 is known to interact with the transcription factor SP1, acting as a co-repressor to regulate gene expression.",
            "effect_description": "This interaction contributes to the silencing of specific gene promoters, although the precise mechanism and full range of target genes are not fully detailed.",
            "biological_consequence": [
              "ATXN3 binds SP1 on chromatin -> Recruitment of repressor complexes -> Transcriptional silencing"
            ],
            "specific_effects": [
              "Normal ATXN3 binds to the promoter of the MMP-2 gene and represses its transcription by recruiting a complex containing HDAC3 and NCoR. [9, 10]",
              "PolyQ-expanded ATXN3 loses this repressor function, leading to aberrant MMP-2 transcription. [9, 19]"
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "year": 2008
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "HSP70",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with Heat Shock Protein 70 (HSP70), specifically Hsc70-4 in Drosophila, via its UIMs, which enhances aggregation and toxicity.",
        "functions": [
          {
            "function": "ATXN3 Aggregation",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with Heat Shock Protein 70 (HSP70/HSPA) chaperones through its ubiquitin-interacting motifs (UIMs).",
            "effect_description": "This interaction, particularly with polyQ-expanded ATXN3, is thought to be a critical step in the formation of protein aggregates, as chaperones are recruited to misfolded proteins. This can paradoxically enhance aggregation and cellular toxicity.",
            "biological_consequence": [
              "Misfolded polyQ-ATXN3 binds HSP70 -> Sequestration of chaperones into aggregates -> Impaired protein quality control -> Enhanced aggregation and toxicity"
            ],
            "specific_effects": [
              "HSP70 is a common component of the neuronal intranuclear inclusions found in SCA3."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "HSP40",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The co-chaperone HSP40 (DNAJ) is recruited to and localizes within the intranuclear inclusions formed by mutant ATXN3, working alongside HSP70.",
        "functions": [
          {
            "function": "ATXN3 Aggregation",
            "arrow": "activates",
            "cellular_process": "The co-chaperone HSP40 (DNAJ family) is recruited to and co-localizes with aggregates formed by polyQ-expanded ATXN3, working in concert with HSP70.",
            "effect_description": "HSP40 acts as a co-chaperone that typically presents misfolded substrates to HSP70. Its presence within ATXN3 inclusions indicates its involvement in the cellular response to misfolded ATXN3, contributing to the aggregation process.",
            "biological_consequence": [
              "Misfolded polyQ-ATXN3 recruits HSP40/HSP70 complex -> Sequestration of chaperone machinery -> Formation of stable intranuclear inclusions -> Cellular toxicity"
            ],
            "specific_effects": [
              "HSP40 is found within the neuronal intranuclear inclusions characteristic of SCA3."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "UBQLN1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Ubiquilin-1 (UBQLN1) is reported to interact with ATXN3 and is involved in protein degradation pathways and aggresome formation.",
        "functions": [
          {
            "function": "Protein Degradation & Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with Ubiquilin-1 (UBQLN1), a protein that links the ubiquitination machinery to the proteasome and is also involved in aggresome formation.",
            "effect_description": "This interaction suggests a cooperative role in managing protein quality control, where both proteins are involved in recognizing and processing ubiquitinated substrates for either degradation or sequestration into aggresomes.",
            "biological_consequence": [
              "ATXN3 and UBQLN1 co-recognize ubiquitinated substrates -> Facilitated delivery to proteasome or aggresome pathway -> Clearance of misfolded proteins"
            ],
            "specific_effects": [
              "UBQLN1 is a component of the cellular machinery for clearing aggregation-prone proteins."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "UBQLN2",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Co-immunoprecipitation studies and analysis of human and mouse brain tissue show that UBQLN2 does not interact with either normal or polyQ-expanded ATXN3. Unlike in Huntington's disease where UBQLN2 is recruited to aggregates, it is absent from ATXN3 inclusions in SCA3.",
        "functions": [
          {
            "function": "Protein Aggregation & Clearance",
            "arrow": "inhibits",
            "cellular_process": "In contrast to other polyglutamine diseases like Huntington's, UBQLN2, a key protein in the ubiquitin-proteasome pathway, does not interact with or co-localize to the protein aggregates formed by polyQ-expanded ATXN3.",
            "effect_description": "This lack of interaction suggests that ATXN3 is not a substrate for UBQLN2-mediated clearance, and the sequestration of protein quality control components by aggregates, a key feature in other neurodegenerative diseases, occurs differently in Spinocerebellar Ataxia Type 3.",
            "biological_consequence": [
              "PolyQ-ATXN3 aggregates form → UBQLN2 is not recruited → ATXN3 aggregates are not processed by UBQLN2-dependent pathways → Highlights a distinct pathomechanism for SCA3 compared to Huntington's disease"
            ],
            "specific_effects": [
              "Co-precipitation studies in cultured cells demonstrated that UBQLN2 fails to interact with normal or expanded ATXN3 protein.",
              "UBQLN2 is recruited to inclusions in Huntington's disease (HD) but not in Spinocerebellar Ataxia Type 3 (SCA3) mouse models and human brain tissue.",
              "The lack of co-localization suggests that components of neuronal protein quality control may be differentially perturbed in distinct polyQ diseases."
            ],
            "evidence": [
              {
                "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
                "year": 2015
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "PSMC6",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 interacts with proteasome subunits, which are found within the neuronal intranuclear inclusions characteristic of SCA3.",
        "functions": [
          {
            "function": "Proteasomal Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with subunits of the 26S proteasome, such as PSMC6 (Rpt4), a component of the 19S regulatory particle.",
            "effect_description": "This interaction places ATXN3 at the site of protein degradation, consistent with its role in processing ubiquitinated substrates before their entry into the proteasome. Proteasome components are also frequently found sequestered within the neuronal inclusions of SCA3.",
            "biological_consequence": [
              "ATXN3 binds to 19S proteasome cap -> Deubiquitinates substrates prior to degradation -> Regulation of protein turnover"
            ],
            "specific_effects": [
              "Proteasome subunits are often found within the intranuclear inclusions formed by mutant ATXN3."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "DYNC1H1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 acts as an adaptor to link polyubiquitinated substrates to the dynein motor protein complex to facilitate transport to the aggresome.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with the dynein motor complex, including the heavy chain DYNC1H1. It acts as an adaptor protein, linking polyubiquitinated protein aggregates to the dynein machinery.",
            "effect_description": "This function is crucial for the retrograde transport of misfolded protein aggregates along microtubules to the microtubule-organizing center (MTOC), where they coalesce to form a perinuclear aggresome.",
            "biological_consequence": [
              "ATXN3 binds ubiquitinated aggregate -> ATXN3 binds DYNC1H1 -> Dynein motor transports aggregate along microtubule -> Delivery to perinuclear aggresome"
            ],
            "specific_effects": [
              "This transport mechanism is dependent on both ATXN3 and HDAC6."
            ],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "HMOX1",
        "interaction_type": "indirect",
        "upstream_interactor": "NRF2",
        "mediator_chain": [
          "NRF2"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly upregulates the expression of Heme Oxygenase 1 (HMOX1) by deubiquitinating and stabilizing the transcription factor NRF2, which then activates HMOX1 transcription.",
        "functions": [
          {
            "function": "HMOX1 Gene Transcription",
            "arrow": "activates",
            "cellular_process": "ATXN3 is proposed to deubiquitinate and stabilize the transcription factor NRF2. This stabilization allows NRF2 to accumulate and translocate to the nucleus, where it binds to the Antioxidant Response Element (ARE) located in the promoter of the Heme Oxygenase 1 (HMOX1) gene.",
            "effect_description": "By promoting the stability and transcriptional activity of NRF2, ATXN3 indirectly upregulates the expression of the cytoprotective enzyme HMOX1, a key component of the cellular defense against oxidative stress.",
            "biological_consequence": [
              "ATXN3 stabilizes NRF2 → NRF2 accumulates in the nucleus → NRF2 binds to the ARE in the HMOX1 promoter → Increased HMOX1 mRNA and protein expression → Heme degradation and production of antioxidant biliverdin/bilirubin"
            ],
            "specific_effects": [
              "HMOX1 is a well-established target gene of the NRF2 transcription factor.",
              "NRF2 activation is a prerequisite for HMOX1 induction in response to oxidative stress."
            ],
            "evidence": [
              {
                "paper_title": "Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1",
                "year": 2008
              },
              {
                "paper_title": "Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "NRF2",
              "chain": [
                "NRF2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "GCLM",
        "interaction_type": "indirect",
        "upstream_interactor": "NRF2",
        "mediator_chain": [
          "NRF2"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly enhances the expression of Glutamate-Cysteine Ligase Modifier Subunit (GCLM) by stabilizing its transcriptional activator, NRF2.",
        "functions": [
          {
            "function": "GCLM Gene Transcription & Glutathione Synthesis",
            "arrow": "activates",
            "cellular_process": "ATXN3 is thought to stabilize the transcription factor NRF2, promoting its nuclear translocation and activity. NRF2 then directly binds to the Antioxidant Response Element (ARE) in the promoter of the Glutamate-Cysteine Ligase Modifier Subunit (GCLM) gene, activating its transcription.",
            "effect_description": "By upregulating GCLM expression via NRF2, ATXN3 indirectly enhances the efficiency of glutamate-cysteine ligase, the rate-limiting enzyme in the synthesis of the major cellular antioxidant glutathione (GSH).",
            "biological_consequence": [
              "ATXN3 stabilizes NRF2 → NRF2 activates GCLM transcription → Increased GCLM protein levels → Enhanced GCL enzyme activity → Increased synthesis of glutathione (GSH) → Improved cellular detoxification and antioxidant capacity"
            ],
            "specific_effects": [
              "NRF2 governs the basal and inducible expression of both GCLC and GCLM subunits of glutamate-cysteine ligase.",
              "A decline in NRF2 transcriptional activity is linked to an age-related loss of glutathione synthesis."
            ],
            "evidence": [
              {
                "paper_title": "Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid",
                "year": 2004
              },
              {
                "paper_title": "Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo",
                "year": 2008
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "NRF2",
              "chain": [
                "NRF2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "SQSTM1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3, playing a role in the formation of aggresomes and protecting cells from cell death.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3. This interaction is crucial for the sequestration of misfolded ATXN3 into larger inclusion bodies.",
            "effect_description": "p62 acts as a scaffold protein that recognizes and binds ubiquitinated protein aggregates, facilitating their collection into aggresomes. This process is considered a protective cellular response to sequester toxic protein species.",
            "biological_consequence": [
              "PolyQ-ATXN3 aggregates form -> SQSTM1 binds to aggregates -> Facilitates coalescence into a single aggresome -> Sequestration of toxic protein -> Cellular protection"
            ],
            "specific_effects": [
              "p62 directly interacts with pathogenic ataxin-3 but not normal ataxin-3.",
              "The interaction is dependent on microtubules.",
              "p62 protects cells against polyQ-expanded ataxin-3-induced cell death."
            ],
            "evidence": [
              {
                "paper_title": "p62/sequestosome 1 regulates aggresome formation of pathogenic ataxin-3 with expanded polyglutamine",
                "year": 2014
              },
              {
                "paper_title": "p62, the Receptor for Selective Autophagy, Contributes in ATXN3 Aggregate Formation in Spinocerebellar Ataxia Type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "SUMO1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is covalently modified by Small Ubiquitin-like Modifier 1 (SUMO-1), a process known as SUMOylation. This direct interaction was identified by yeast two-hybrid and confirmed by co-immunoprecipitation, and it is thought to regulate the biological function of ATXN3.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "ATXN3 is post-translationally modified by covalent attachment of Small Ubiquitin-like Modifier 1 (SUMO-1). This process, known as SUMOylation, is catalyzed by a cascade of E1, E2 (UBC9), and E3 (e.g., PIAS1) enzymes.",
            "effect_description": "SUMOylation of ATXN3, particularly at lysine 166, enhances its protein stability by competing with ubiquitination and preventing its degradation by the proteasome.",
            "biological_consequence": [
              "SUMO1 is conjugated to ATXN3 -> Prevents ubiquitin chain attachment -> Reduced proteasomal degradation -> Increased ATXN3 protein stability"
            ],
            "specific_effects": [
              "SUMO modification at K166 of polyQ-expanded ATXN3 enhances its stability."
            ],
            "evidence": [
              {
                "paper_title": "PIAS1 promotes ATXN3 SUMOylation and enhances its protein stability",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "PIAS1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The SUMO E3 ligase PIAS1 directly interacts with ATXN3 to promote its SUMOylation. This interaction stabilizes ATXN3 by preventing its proteasome-mediated degradation.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "The SUMO E3 ligase PIAS1 directly interacts with ATXN3 and promotes its conjugation with SUMO proteins.",
            "effect_description": "By catalyzing the SUMOylation of ATXN3, PIAS1 increases the stability of both wild-type and polyQ-expanded ATXN3, protecting it from proteasome-mediated degradation.",
            "biological_consequence": [
              "PIAS1 binds ATXN3 -> Catalyzes SUMO attachment -> Reduced ATXN3 ubiquitination -> Increased ATXN3 protein levels"
            ],
            "specific_effects": [
              "PIAS1 knockdown leads to a dose-dependent decrease in both wild-type and mutant ATXN3 protein levels.",
              "The stabilization of ATXN3 by PIAS1 is prevented by treatment with the proteasome inhibitor MG132."
            ],
            "evidence": [
              {
                "paper_title": "PIAS1 S510G variant acts as a genetic modifier of spinocerebellar ataxia type 3 by selectively impairing mutant ataxin-3 proteostasis",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "UBC9",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "As the primary E2 SUMO-conjugating enzyme, UBC9 is a necessary and direct interactor for the SUMOylation of ATXN3, working in concert with E3 ligases like PIAS1.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "UBC9 is the essential E2 SUMO-conjugating enzyme that directly interacts with ATXN3 and transfers the activated SUMO moiety to it, a process facilitated by an E3 ligase like PIAS1.",
            "effect_description": "As the sole E2 enzyme for SUMOylation, UBC9 is indispensable for the covalent modification of ATXN3 with SUMO, which in turn regulates ATXN3's stability and function.",
            "biological_consequence": [
              "Activated SUMO is transferred to UBC9 -> UBC9/PIAS1/ATXN3 form a complex -> SUMO is covalently attached to ATXN3 -> ATXN3 stability is enhanced"
            ],
            "specific_effects": [
              "The SUMOylation pathway involves the sequential action of E1, E2 (UBC9), and E3 enzymes."
            ],
            "evidence": [
              {
                "paper_title": "Conserved residues within PIAS1 and UBC9 play a key role in the...",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "SRSF7",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly interacts with and deubiquitinates the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), thereby regulating its stability and influencing mRNA splicing processes, including that of the MAPT (Tau) gene.",
        "functions": [
          {
            "function": "mRNA Splicing",
            "arrow": "activates",
            "cellular_process": "ATXN3 functions as a deubiquitinase for the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), removing polyubiquitin chains to regulate its stability and activity.",
            "effect_description": "By stabilizing SRSF7, ATXN3 influences the alternative splicing of various target mRNAs. A notable target is MAPT (Tau), where ATXN3 loss leads to a decreased 4R/3R-Tau ratio, linking ATXN3 function to another key protein in neurodegeneration.",
            "biological_consequence": [
              "ATXN3 deubiquitinates SRSF7 -> SRSF7 is stabilized -> Altered alternative splicing of target genes (e.g., MAPT) -> Changes in protein isoform ratios"
            ],
            "specific_effects": [
              "Loss of ATXN3 leads to altered polyubiquitylation of multiple proteins involved in RNA metabolism.",
              "Loss of ATXN3 deregulates MAPT exon 10 splicing."
            ],
            "evidence": [
              {
                "paper_title": "Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "TUBB",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 directly binds to tubulin with high affinity (around 50nM). This interaction is crucial for the microtubule-dependent transport of protein aggregates to the aggresome.",
        "functions": [
          {
            "function": "Microtubule-Dependent Aggregate Transport",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly binds to tubulin, the main component of microtubules, with high affinity.",
            "effect_description": "This interaction is essential for linking protein aggregates to the microtubule network, enabling their transport by motor proteins like dynein to the aggresome. This function is a key part of the cellular response to misfolded protein stress.",
            "biological_consequence": [
              "ATXN3 binds aggregate -> ATXN3 binds tubulin/microtubules -> Aggregate is trafficked along microtubule network -> Sequestration in the aggresome"
            ],
            "specific_effects": [],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "KLF4",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 functions as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), indicating a direct enzyme-substrate interaction that regulates KLF4 stability.",
        "functions": [
          {
            "function": "KLF4 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), directly binding to it and removing polyubiquitin chains.",
            "effect_description": "By preventing its proteasomal degradation, ATXN3 stabilizes and increases the protein levels of KLF4. In the context of breast cancer, this stabilization promotes cancer cell metastasis.",
            "biological_consequence": [
              "ATXN3 deubiquitinates KLF4 -> KLF4 protein is stabilized -> Increased KLF4 levels -> Promotion of breast cancer metastasis"
            ],
            "specific_effects": [
              "ATXN3 was identified as a KLF4 deubiquitinase from a screen of 65 DUBs.",
              "High expression of both ATXN3 and KLF4 is associated with a poor prognosis in breast cancer patients."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "PJA1",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The E3 ubiquitin ligase PJA1 (also known as RING finger protein 127) directly interacts with ATXN3 to promote its ubiquitination and subsequent degradation by both the proteasome and autophagy.",
        "functions": [
          {
            "function": "ATXN3 Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "The E3 ubiquitin ligase PJA1 (Praja1) interacts with and ubiquitinates ATXN3, targeting it for degradation.",
            "effect_description": "PJA1 promotes the degradation of both wild-type and polyQ-expanded ATXN3 through both the proteasome and autophagy pathways, thereby reducing ATXN3 protein levels and suppressing aggregate formation.",
            "biological_consequence": [
              "PJA1 ubiquitinates ATXN3 -> ATXN3 is targeted for degradation -> Reduced ATXN3 protein levels and aggregation -> Suppression of polyQ toxicity"
            ],
            "specific_effects": [
              "PJA1 expression is diminished when polyQ-expanded proteins are expressed.",
              "PJA1 promotes ATXN3 degradation by both the proteasome and autophagy."
            ],
            "evidence": [
              {
                "paper_title": "Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity",
                "year": 2018
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "AMFR",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "The E3 ubiquitin ligase AMFR (also known as Gp78) directly polyubiquitinates ATXN3, targeting it for degradation through the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway.",
        "functions": [
          {
            "function": "ATXN3 Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "The E3 ubiquitin ligase AMFR (gp78), an enzyme involved in Endoplasmic Reticulum-Associated Degradation (ERAD), directly interacts with and polyubiquitinates ATXN3.",
            "effect_description": "This ubiquitination by AMFR targets ATXN3 for degradation via the ERAD pathway, playing a role in the quality control and turnover of ATXN3.",
            "biological_consequence": [
              "AMFR ubiquitinates ATXN3 -> ATXN3 is targeted to the ERAD pathway -> Proteasomal degradation of ATXN3"
            ],
            "specific_effects": [
              "Overexpression of gp78 promotes the ubiquitination and degradation of ATXN3.",
              "Knockdown of gp78 stabilizes ATXN3 protein."
            ],
            "evidence": [
              {
                "paper_title": "Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation",
                "year": 2009
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "CAMK2A",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "Proteomic analysis of ATXN3 pull-downs from mouse brain tissue revealed that mutant ATXN3 abnormally interacts with Calcium/calmodulin-dependent protein kinase II subunit alpha (Camk2a), a component of large protein complexes.",
        "functions": [
          {
            "function": "Protein Complex Formation",
            "arrow": "activates",
            "cellular_process": "Proteomic analysis of brain lysates from a SCA3 mouse model revealed that mutant, polyQ-expanded ATXN3 abnormally interacts with Camk2a, a subunit of the Calcium/calmodulin-dependent protein kinase II complex.",
            "effect_description": "This abnormal interaction suggests that mutant ATXN3 can sequester key neuronal proteins into large, insoluble complexes or aggregates, potentially disrupting their normal functions, such as mitochondrial transport in axons.",
            "biological_consequence": [
              "Mutant ATXN3 binds CAMK2A -> Sequestration into large protein complexes/aggregates -> Disruption of normal CAMK2A function (e.g., synaptic plasticity, transport)"
            ],
            "specific_effects": [
              "Mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5, Cct6, Tcp1, Camk2a and Camk2b."
            ],
            "evidence": [
              {
                "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      },
      {
        "primary": "PTEN",
        "interaction_type": "direct",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 1,
        "support_summary": "ATXN3 is suggested to directly regulate the tumor suppressor PTEN, with evidence pointing to a deubiquitinase-substrate relationship that inhibits PTEN's anti-oncogene function in certain cancers.",
        "functions": [
          {
            "function": "PTEN Transcription",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 acts as a transcriptional repressor of the tumor suppressor gene PTEN. This regulation is independent of ATXN3's deubiquitinase activity on the PTEN protein itself.",
            "effect_description": "By repressing PTEN transcription, ATXN3 can contribute to the hyperactivation of the PI3K/Akt signaling pathway, which is a common event in cancer. Depletion of ATXN3 leads to increased PTEN mRNA levels.",
            "biological_consequence": [
              "ATXN3 represses PTEN promoter -> Decreased PTEN mRNA and protein -> Reduced antagonism of PI3K pathway -> Increased Akt phosphorylation and signaling"
            ],
            "specific_effects": [
              "Depletion of ATXN3 increases PTEN transcript abundance but does not alter PTEN protein stability.",
              "ATXN3 depletion is sufficient to downregulate Akt phosphorylation."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells",
                "year": 2014
              },
              {
                "paper_title": "The equilibrium of tumor suppression: DUBs as active regulators of PTEN",
                "year": 2022
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        }
      },
      {
        "primary": "MBNL1",
        "interaction_type": "indirect",
        "upstream_interactor": null,
        "mediator_chain": [],
        "depth": 2,
        "support_summary": "ATXN3 indirectly affects the splicing factor Muscleblind-like Splicing Regulator 1 (MBNL1). The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms hairpin structures that sequester MBNL1 into nuclear foci, leading to its functional inactivation and subsequent misregulation of alternative splicing.",
        "functions": [
          {
            "function": "MBNL1 Splicing Activity",
            "arrow": "inhibits",
            "cellular_process": "The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms toxic hairpin structures in the nucleus. These RNA structures act as a scaffold to sequester the Muscleblind-like Splicing Regulator 1 (MBNL1).",
            "effect_description": "This sequestration leads to the functional inactivation of MBNL1, preventing it from regulating the alternative splicing of its target pre-mRNAs. This loss-of-function mechanism contributes to the spliceopathy observed in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 gene is transcribed into toxic RNA -> RNA hairpins sequester MBNL1 into nuclear foci -> MBNL1 is functionally depleted -> Misregulation of alternative splicing -> Cellular dysfunction"
            ],
            "specific_effects": [
              "The sequestration of MBNL1 into nuclear RNA foci by expanded CAG repeats is a shared pathomechanism with myotonic dystrophy type 1. [3, 28]"
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "inhibits",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "inhibits"
          ]
        },
        "_chain_inferred": true
      },
      {
        "primary": "MAPT",
        "interaction_type": "indirect",
        "upstream_interactor": "SRSF7",
        "mediator_chain": [
          "SRSF7"
        ],
        "depth": 2,
        "support_summary": "ATXN3 indirectly regulates the alternative splicing of Microtubule-Associated Protein Tau (MAPT) by controlling the stability of the splicing factor SRSF7.",
        "functions": [
          {
            "function": "MAPT (Tau) Alternative Splicing",
            "arrow": "activates",
            "cellular_process": "ATXN3 deubiquitinates and stabilizes the splicing factor SRSF7. SRSF7 is a key regulator of MAPT (Tau) exon 10 splicing, which determines the ratio of 4-repeat (4R) to 3-repeat (3R) Tau isoforms.",
            "effect_description": "By maintaining SRSF7 levels, wild-type ATXN3 ensures the proper 4R/3R-Tau ratio. Loss of ATXN3 function, or its dysfunction in SCA3, leads to reduced SRSF7 levels and a decreased 4R/3R-Tau ratio, linking SCA3 pathology to tauopathy.",
            "biological_consequence": [
              "ATXN3 stabilizes SRSF7 → Proper regulation of MAPT exon 10 splicing → Maintained 4R/3R-Tau ratio → Normal neuronal function"
            ],
            "specific_effects": [
              "Loss of ATXN3 function leads to a decreased 4R/3R-Tau ratio.",
              "Similar splicing alterations are observed in cellular models of SCA3 and in patient brains."
            ],
            "evidence": [
              {
                "paper_title": "Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors",
                "year": 2019
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "SRSF7",
              "chain": [
                "SRSF7"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ],
        "arrow": "activates",
        "direction": "main_to_primary",
        "intent": "regulation",
        "arrows": {
          "main_to_primary": [
            "activates"
          ]
        }
      }
    ],
    "interactor_history": [
      "VCP",
      "PARK2",
      "HDAC6",
      "RAD23A",
      "RAD23B",
      "STUB1",
      "TP53",
      "PNKP",
      "MDC1",
      "CHEK1",
      "BECN1",
      "YAP1",
      "HDAC3",
      "CREBBP",
      "EP300",
      "KEAP1",
      "BCL2",
      "SOD2",
      "BAX",
      "FOXO4",
      "NRF2",
      "TRAF6",
      "LC3",
      "PML",
      "SP1",
      "HSP70",
      "HSP40",
      "UBQLN1",
      "UBQLN2",
      "PSMC6",
      "DYNC1H1",
      "HMOX1",
      "GCLM",
      "SQSTM1",
      "SUMO1",
      "PIAS1",
      "UBC9",
      "SRSF7",
      "TUBB",
      "KLF4",
      "PJA1",
      "AMFR",
      "CAMK2A",
      "PTEN",
      "MBNL1",
      "MAPT"
    ],
    "search_history": [
      "ATXN3 protein-protein interactions",
      "ATXN3 direct binding partners",
      "ATXN3 interactome",
      "ATXN3 function and pathways",
      "ATXN3 deubiquitinase substrates",
      "ATXN3 role in protein quality control",
      "ATXN3 interactors ubiquitin proteasome system",
      "ATXN3 transcriptional regulation partners",
      "proteins in ATXN3 aggregates SCA3",
      "ATXN3 NRF2 pathway",
      "ATXN3 FOXO4 regulation",
      "ATXN3 interactome mass spectrometry",
      "ATXN3 RNA-binding protein interactors",
      "ATXN3 splicing factors interaction",
      "ATXN3 deubiquitinase novel substrates",
      "ATXN3 SUMO pathway interaction",
      "ATXN3 aggresome formation interactors",
      "ATXN3 YAP1 deubiquitination stability",
      "ATXN3 HDAC3 ubiquitination transcriptional regulation",
      "ATXN3 CREBBP p300 transcriptional regulation",
      "ATXN3 KEAP1 stability deubiquitination",
      "ATXN3 FOXO4 oxidative stress SOD2 transcription",
      "ATXN3 NRF2 stability antioxidant response",
      "ATXN3 TRAF6 deubiquitination immune signaling",
      "ATXN3 LC3 LIR motif autophagy",
      "ATXN3 PML nuclear bodies interaction",
      "ATXN3 SP1 transcriptional repression",
      "ATXN3 SP1 transcriptional repression mechanism",
      "ATXN3 interaction with HSP70 and HSP40",
      "ATXN3 UBQLN1 protein degradation pathway",
      "ATXN3 interaction with proteasome subunit PSMC6",
      "ATXN3 DYNC1H1 dynein aggresome transport",
      "ATXN3 SQSTM1 p62 aggresome formation",
      "ATXN3 SUMOylation pathway PIAS1 UBC9",
      "ATXN3 deubiquitinates SRSF7 splicing factor",
      "ATXN3 tubulin binding microtubule transport",
      "ATXN3 deubiquitinates KLF4 stability",
      "PJA1 E3 ligase for ATXN3 degradation",
      "AMFR Gp78 E3 ligase for ATXN3 ERAD",
      "mutant ATXN3 interaction with CAMK2A",
      "ATXN3 regulation of PTEN deubiquitination",
      "mutant ATXN3 RNA sequestration of MBNL1",
      "ATXN3 and Bcl-2 regulation via Parkin",
      "ATXN3 and BAX expression via p53",
      "ATXN3 and HMOX1 GCLM expression via NRF2",
      "ATXN3 TRAF6 type I interferon response",
      "ATXN3 deubiquitinates TRAF6 IRF3",
      "ATXN3 STUB1 chaperone-mediated degradation",
      "ATXN3 deubiquitinates Tau via CHIP",
      "ATXN3 deubiquitinates PTEN protein stability",
      "ATXN3 PTEN PI3K/Akt pathway",
      "ATXN3 stabilizes NRF2 antioxidant response",
      "ATXN3 KEAP1 NRF2 interaction",
      "ATXN3 Parkin mitophagy PINK1",
      "ATXN3 role in Parkin-mediated mitophagy",
      "ATXN3 Beclin 1 Bcl-2 interaction apoptosis",
      "ATXN3 regulates Beclin 1 apoptosis",
      "ATXN3 VCP autophagosome maturation",
      "ATXN3 VCP role in autophagy flux",
      "ATXN3 HDAC6 cell motility",
      "ATXN3 HDAC6 tubulin deacetylation",
      "ATXN3 Hippo pathway regulation",
      "ATXN3 LATS1 LATS2 YAP1",
      "ATXN3 KLF4 stem cell maintenance",
      "ATXN3 KLF4 pluripotency",
      "ATXN3 Parkin BCL2 regulation mitophagy",
      "Parkin ubiquitination of BCL2",
      "ATXN3 FOXO4 SOD2 gene expression",
      "FOXO4 transcriptional regulation of SOD2",
      "ATXN3 NRF2 HMOX1 gene expression",
      "NRF2 antioxidant response element HMOX1",
      "ATXN3 NRF2 GCLM gene expression",
      "NRF2 antioxidant response element GCLM",
      "ATXN3 UBQLN2 interaction",
      "ataxin-3 ubiquilin-2 function",
      "UBQLN2 in spinocerebellar ataxia type 3 pathology",
      "ATXN3 deubiquitination of TRAF6 specific effects",
      "mutant ataxin-3 PML nuclear bodies specific effects",
      "ataxin-3 SP1 transcriptional repression specific effects",
      "ATXN3 tubulin binding affinity microtubule transport",
      "mutant ATXN3 RNA sequestration of MBNL1 specific effects",
      "ATXN3 TRAF6 IRF3 activation",
      "ATXN3 PML-NBs DNA damage response",
      "ATXN3 SP1 MMP-2 promoter",
      "ATXN3 MBNL1 splicing targets SCA3"
    ],
    "function_batches": [
      "VCP",
      "PARK2",
      "HDAC6",
      "RAD23A",
      "RAD23B",
      "STUB1",
      "TP53",
      "PNKP",
      "MDC1",
      "CHEK1",
      "BECN1",
      "YAP1",
      "HDAC3",
      "CREBBP",
      "EP300",
      "KEAP1",
      "FOXO4",
      "NRF2",
      "TRAF6",
      "LC3",
      "PML",
      "SP1",
      "HSP70",
      "HSP40",
      "UBQLN1",
      "PSMC6",
      "DYNC1H1",
      "SQSTM1",
      "SUMO1",
      "PIAS1",
      "UBC9",
      "SRSF7",
      "TUBB",
      "KLF4",
      "PJA1",
      "AMFR",
      "CAMK2A",
      "PTEN",
      "MBNL1",
      "BAX",
      "MAPT",
      "UBQLN2"
    ]
  },
  "snapshot_json": {
    "main": "ATXN3",
    "interactors": [
      {
        "primary": "VCP",
        "direction": "bidirectional",
        "arrow": "regulates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with VCP/p97, an AAA+ ATPase involved in protein quality control, via a VCP binding motif (VBM) on ATXN3. This interaction is crucial for processes like ER-associated degradation (ERAD).",
        "functions": [
          {
            "function": "ER-Associated Degradation (ERAD)",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 binds to VCP/p97 via its VCP-binding motif (VBM) and competes with other VCP cofactors like Ufd1. This interaction modulates the extraction of ubiquitinated substrates from the endoplasmic reticulum.",
            "effect_description": "By binding to VCP, ATXN3 reduces the retrotranslocation of misfolded proteins from the ER to the cytosol for proteasomal degradation, thereby acting as a negative regulator of the ERAD pathway's flow.",
            "biological_consequence": [
              "ATXN3 binding to VCP → Sequesters VCP from other cofactors (e.g., Ufd1/Npl4) → Decreased extraction of ERAD substrates → Accumulation of misfolded proteins in the ER → ER stress"
            ],
            "specific_effects": [
              "ATXN3 and Ufd1 bind to VCP in a mutually exclusive manner.",
              "ATXN3 decreases the interaction of VCP with ubiquitylated proteins.",
              "Pathological polyQ expansion in ATXN3 enhances VCP binding, leading to greater impairment of ERAD."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
                "year": 2006
              },
              {
                "paper_title": "The Machado-Joseph disease deubiquitylase ataxin-3 couples pulldown and deubiquitylation of ubiquitylated proteins",
                "year": 2020
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Lysosome Regeneration",
            "arrow": "activates",
            "cellular_process": "Following lysosomal membrane damage, ATXN3 and its partner VCP/p97 are recruited to a subset of recovering lysosomes. There, they target and process K48-K63-branched ubiquitin chains on lysosomal proteins, such as LAMP2.",
            "effect_description": "This processing facilitates the degradation of a fraction of LAMP2 via microautophagy, which helps to regenerate the lysosomal membrane and restore the overall degradative capacity of the lysosomal system.",
            "biological_consequence": [
              "Lysosomal damage → ATXN3/VCP recruitment → Processing of branched ubiquitin chains on LAMP2 → LAMP2 degradation via microautophagy → Lysosomal membrane regeneration → Restoration of cellular degradative capacity"
            ],
            "specific_effects": [
              "ATXN3 is required for lysophagic flux after lysosomal damage but not for the initial phagophore formation.",
              "The ATXN3-VCP complex specifically targets K48-K63-branched ubiquitin conjugates on regenerating lysosomes."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains",
                "year": 2025
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "PI3K Complex Assembly and Activity",
            "arrow": "activates",
            "cellular_process": "VCP/p97 interacts with components of the class III PI3K complex, including BECN1 and ATG14. VCP stimulates the deubiquitinase activity of ATXN3, which in turn stabilizes BECN1.",
            "effect_description": "By promoting the stabilization of BECN1 and the assembly of the PI3K complex, VCP enhances the production of phosphatidylinositol-3-phosphate (PtdIns3P), a critical step for initiating autophagosome formation.",
            "biological_consequence": [
              "VCP activates ATXN3 DUB activity → ATXN3 stabilizes BECN1 → VCP promotes PI3K complex assembly → Increased PtdIns3P production → Recruitment of early autophagy markers (WIPI2, ATG16L1) → Autophagy initiation"
            ],
            "specific_effects": [
              "VCP's role in autophagy initiation is in addition to its known role in autophagosome maturation.",
              "Acute inhibition of VCP impairs PtdIns3P production and the recruitment of early autophagy machinery."
            ],
            "evidence": [
              {
                "paper_title": "VCP/p97 modulates PtdIns3P production and autophagy initiation",
                "year": 2021
              },
              {
                "paper_title": "New functions of a known autophagy regulator: VCP and autophagy initiation",
                "year": 2021
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PARK2",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with and deubiquitinates the E3 ubiquitin ligase Parkin (PARK2), thereby regulating its activity. This interaction is implicated in pathways related to both protein degradation and neurodegenerative diseases like Parkinson's.",
        "functions": [
          {
            "function": "Parkin Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "PolyQ-expanded ATXN3 enhances the deubiquitination of Parkin, with a preference for cleaving K27- and K29-linked ubiquitin chains that may protect Parkin from autophagic degradation.",
            "effect_description": "By preferentially removing these protective ubiquitin chains, mutant ATXN3 promotes the autophagic degradation of Parkin, leading to reduced Parkin levels. This gain of toxic function may contribute to parkinsonian features in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 deubiquitinates PARK2 (cleaves K27/K29 chains) → Increased PARK2 turnover → Enhanced autophagic degradation of PARK2 → Reduced PARK2 protein levels → Impaired mitophagy and mitochondrial quality control"
            ],
            "specific_effects": [
              "This effect is specific to polyQ-expanded ATXN3 and leads to a reduction of Parkin levels in MJD mouse models.",
              "The loss of Parkin function is a primary cause of familial Parkinson's disease."
            ],
            "evidence": [
              {
                "paper_title": "Mutant ataxin-3 promotes the autophagic degradation of parkin",
                "year": 2011
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "HDAC6",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly binds to Histone Deacetylase 6 (HDAC6). This interaction is involved in the cellular machinery that sorts protein aggregates to the aggresome via microtubules.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with HDAC6, a key component of the machinery that transports misfolded protein aggregates to the aggresome. ATXN3's DUB activity generates unanchored ubiquitin C-termini on aggregates, which are then recognized by the ubiquitin-binding domain of HDAC6.",
            "effect_description": "This interaction facilitates the recruitment of misfolded protein aggregates to the dynein motor complex for retrograde transport along microtubules to the perinuclear aggresome.",
            "biological_consequence": [
              "ATXN3 trims ubiquitin chains on aggregates → Exposes ubiquitin C-termini → HDAC6 binds exposed C-termini → HDAC6 links aggregate to Dynein motor → Transport to aggresome"
            ],
            "specific_effects": [
              "ATXN3, HDAC6, and dynein are part of a complex that has ubiquitin protease activity.",
              "Depletion of ATXN3 leads to decreased aggresome formation.",
              "HDAC6 recognizes and binds to unanchored C-terminal diglycine motifs of ubiquitin generated by ATXN3 on protein aggregates."
            ],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              },
              {
                "paper_title": "Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini",
                "year": 2012
              },
              {
                "paper_title": "The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Actin-Dependent Cell Motility",
            "arrow": "activates",
            "cellular_process": "ATXN3 stabilizes HDAC6, which in turn deacetylates the F-actin-binding protein cortactin. The acetylation status of cortactin modulates its ability to bind F-actin.",
            "effect_description": "By increasing HDAC6 levels, ATXN3 indirectly promotes the deacetylation of cortactin, which alters actin cytoskeleton dynamics and enhances cell motility.",
            "biological_consequence": [
              "ATXN3 stabilizes HDAC6 → Increased HDAC6 activity → Deacetylation of cortactin → Altered cortactin-F-actin binding → Modulation of actin cytoskeleton → Enhanced cell motility"
            ],
            "specific_effects": [
              "HDAC6 influences actin-dependent cell motility in addition to its role in microtubule-dependent transport."
            ],
            "evidence": [
              {
                "paper_title": "HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "RAD23A",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with the proteasome-associated protein RAD23A (hHR23A), which is involved in delivering ubiquitinated substrates to the proteasome and also prevents the proteasomal degradation of ATXN3 itself.",
        "functions": [
          {
            "function": "Proteasome-Mediated Protein Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with RAD23A (hHR23A), a shuttle protein that delivers ubiquitinated substrates to the 26S proteasome for degradation.",
            "effect_description": "This interaction links ATXN3 to the proteasomal degradation pathway, potentially influencing the fate of ubiquitinated proteins by either promoting their delivery to the proteasome or deubiquitinating them prior to degradation.",
            "biological_consequence": [
              "ATXN3 binds RAD23A → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome"
            ],
            "specific_effects": [
              "ATXN3's interaction with Rad23 homologs suggests it can monitor proteasome traffic and the delivery of ubiquitylated proteins.",
              "The interaction between ATXN3 and RAD23A has been confirmed by co-immunoprecipitation."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A",
                "year": 1999
              },
              {
                "paper_title": "Physiological and pathophysiological characteristics of ataxin-3 isoforms",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "RAD23B",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which plays a similar role in the ubiquitin-proteasome system and in protecting ATXN3 from degradation.",
        "functions": [
          {
            "function": "Proteasome-Mediated Protein Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which functions as a shuttle protein to deliver ubiquitinated substrates to the 26S proteasome.",
            "effect_description": "This interaction connects ATXN3 to the ubiquitin-proteasome system, where it can influence the processing of substrates destined for degradation.",
            "biological_consequence": [
              "ATXN3 binds RAD23B → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome"
            ],
            "specific_effects": [
              "ATXN3's interaction with Rad23 homologs is implicated in its role in ERAD.",
              "The interaction between ATXN3 and RAD23B has been confirmed by co-immunoprecipitation."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A",
                "year": 1999
              },
              {
                "paper_title": "Physiological and pathophysiological characteristics of ataxin-3 isoforms",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "STUB1",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with and deubiquitinates STUB1 (CHIP), an E3 ubiquitin ligase, thereby modulating its activity within the ubiquitin-proteasome system.",
        "functions": [
          {
            "function": "Chaperone-Mediated Substrate Degradation",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 collaborates with the E3 ligase STUB1/CHIP and chaperones (e.g., HSP70) in the degradation of misfolded substrates via pathways like chaperone-mediated autophagy (CMA) and the proteasome.",
            "effect_description": "ATXN3 modulates this process by trimming the length of ubiquitin chains that CHIP adds to substrates. This editing function can alter the fate of the substrate, preventing excessive ubiquitination and potentially diverting it from immediate degradation.",
            "biological_consequence": [
              "Misfolded substrate binds HSP70/CHIP complex → CHIP ubiquitinates substrate → ATXN3 trims polyubiquitin chains → Modulated signal for degradation (proteasome or CMA) → Altered substrate turnover"
            ],
            "specific_effects": [
              "STUB1/CHIP is required for the CMA-mediated degradation of substrates like HIF1A.",
              "ATXN3 restricts the length of ubiquitin chains attached to STUB1/CHIP substrates, preventing further chain extension."
            ],
            "evidence": [
              {
                "paper_title": "STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy",
                "year": 2013
              },
              {
                "paper_title": "Co-Chaperone HSJ1a Dually Regulates the Proteasomal Degradation of Ataxin-3",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "TP53",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly binds to and stabilizes the tumor suppressor p53 (TP53) by removing polyubiquitin chains, thereby preventing its degradation and promoting p53-mediated signaling.",
        "functions": [
          {
            "function": "TP53 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a deubiquitinase for the tumor suppressor p53 (TP53). It binds directly to both native and polyubiquitinated p53 and removes ubiquitin chains, protecting it from proteasomal degradation.",
            "effect_description": "By stabilizing p53, ATXN3 enhances its transcriptional activity and promotes p53-mediated cellular responses like apoptosis and cell cycle arrest.",
            "biological_consequence": [
              "ATXN3 deubiquitinates TP53 → TP53 protein stabilization → Increased TP53 transcriptional activity → Enhanced p53-dependent apoptosis and cell cycle arrest."
            ],
            "specific_effects": [
              "ATXN3 deletion destabilizes p53, leading to reduced p53 activity.",
              "ATXN3 stabilizes p53 via the ubiquitin-proteasome pathway, not the lysosomal pathway.",
              "PolyQ-expanded ATXN3 has an enhanced ability to bind and deubiquitinate p53, leading to prolonged p53 signaling and increased apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53",
                "year": 2015
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PNKP",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 forms a direct complex with Polynucleotide Kinase 3'-Phosphatase (PNKP) to promote its phosphatase activity, playing a role in DNA single-strand break repair.",
        "functions": [
          {
            "function": "DNA Strand Break Repair",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 forms a complex with Polynucleotide Kinase 3'-Phosphatase (PNKP), a key enzyme in the repair of DNA single- and double-strand breaks. This interaction promotes PNKP's 3'-phosphatase activity.",
            "effect_description": "By enhancing PNKP's enzymatic activity, ATXN3 facilitates the efficient repair of DNA strand breaks, thereby maintaining genome integrity.",
            "biological_consequence": [
              "ATXN3 binds PNKP → Promotes PNKP phosphatase activity → Efficient processing of 3'-phosphate termini at DNA breaks → Facilitates DNA single-strand and double-strand break repair."
            ],
            "specific_effects": [
              "PNKP is a dual-function enzyme involved in single-strand break repair and nonhomologous end joining.",
              "Mutant, polyQ-expanded ATXN3 inhibits PNKP activity, leading to the accumulation of DNA damage."
            ],
            "evidence": [
              {
                "paper_title": "Wild-type Ataxin-3 promotes error-free DNA repair and maintains genome stability, whereas the mutant form compromises this function",
                "year": 2015
              },
              {
                "paper_title": "Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3",
                "year": 2015
              },
              {
                "paper_title": "Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "MDC1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "As a deubiquitinase, ATXN3 directly counteracts the polyubiquitination of Mediator Of DNA Damage Checkpoint 1 (MDC1), prolonging its presence on chromatin and ensuring proper DNA damage response activation.",
        "functions": [
          {
            "function": "DNA Damage Response Signaling",
            "arrow": "activates",
            "cellular_process": "In the early phase of the DNA double-strand break (DSB) response, ATXN3 acts as a deubiquitinase for the checkpoint mediator MDC1. It counteracts the activity of the SUMO-targeted ubiquitin ligase RNF4, which promotes MDC1's removal from chromatin.",
            "effect_description": "By deubiquitinating MDC1, ATXN3 prevents its premature removal from DNA lesions, prolonging its chromatin dwell time and ensuring a robust and consolidated activation of the downstream DNA damage response cascade.",
            "biological_consequence": [
              "ATXN3 counteracts RNF4-mediated MDC1 ubiquitination → Increased MDC1 residence time at DSBs → Efficient recruitment of downstream factors (RNF8, RNF168, BRCA1, 53BP1) → Robust DNA repair signaling."
            ],
            "specific_effects": [
              "Loss of ATXN3 reduces the chromatin dwell time of MDC1 at DSBs.",
              "ATXN3 is required for efficient MDC1-dependent DSB repair by both non-homologous end-joining and homologous recombination.",
              "ATXN3 is recruited to DSBs in a SUMOylation-dependent manner."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4",
                "year": 2017
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "CHEK1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with Checkpoint Kinase 1 (CHEK1) and prevents its polyubiquitination and subsequent degradation, which is important for facilitating DNA damage checkpoints and repair.",
        "functions": [
          {
            "function": "DNA Damage Checkpoint Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with the checkpoint kinase Chk1 and protects it from polyubiquitination and subsequent proteasomal degradation mediated by E3 ligases like DDB1/CUL4A and FBXO6/CUL1.",
            "effect_description": "By deubiquitinating and stabilizing Chk1, ATXN3 maintains the steady-state levels of Chk1, which is essential for proper activation of DNA damage checkpoints (e.g., G2/M checkpoint) and facilitating DNA repair.",
            "biological_consequence": [
              "ATXN3 deubiquitinates CHEK1 → CHEK1 protein stabilization → Maintenance of CHEK1 levels → Proper G2/M checkpoint arrest upon DNA damage → Genome integrity."
            ],
            "specific_effects": [
              "ATXN3 deficiency leads to a pronounced reduction of Chk1 levels and compromises the G2/M checkpoint.",
              "Under prolonged replication stress, Chk1 is phosphorylated and dissociates from ATXN3, allowing for its degradation and checkpoint termination."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 promotes genome integrity by stabilizing Chk1",
                "year": 2017
              },
              {
                "paper_title": "Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint",
                "year": 2000
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "BECN1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly deubiquitinates Beclin 1 (BECN1), a key protein in autophagy, leading to its stabilization and the stimulation of the autophagic process.",
        "functions": [
          {
            "function": "Apoptosis/Autophagy Checkpoint",
            "arrow": "activates",
            "cellular_process": "BECN1 is a key protein that integrates apoptosis and autophagy signaling, partly through its inhibitory interaction with the anti-apoptotic protein Bcl-2 at the endoplasmic reticulum.",
            "effect_description": "By deubiquitinating and stabilizing BECN1, ATXN3 increases the total pool of BECN1 available to participate in cellular signaling. This can influence the threshold for inducing either autophagy (when BECN1 is released from Bcl-2) or apoptosis, thus modulating the cell's life/death decision.",
            "biological_consequence": [
              "ATXN3 stabilizes BECN1 → Increased BECN1 protein pool → Modulates the equilibrium of the BECN1-Bcl-2 complex → Influences the switch between autophagy and apoptosis"
            ],
            "specific_effects": [
              "The interaction between Bcl-2 and BECN1 inhibits autophagy.",
              "Disruption of the Bcl-2/BECN1 complex is a key step in autophagy induction.",
              "Caspase-mediated cleavage of BECN1 can generate fragments that promote apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch",
                "year": 2013
              },
              {
                "paper_title": "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy",
                "year": 2005
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "YAP1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 functions as a deubiquitinase for Yes-associated protein 1 (YAP1), removing polyubiquitin chains to protect it from degradation and thereby promoting its oncogenic activity.",
        "functions": [
          {
            "function": "YAP1 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with, deubiquitinates, and stabilizes the Hippo pathway effector YAP1. By removing K48-linked polyubiquitin chains, ATXN3 prevents the proteasomal degradation of YAP1.",
            "effect_description": "This stabilization increases the overall protein levels of YAP1, allowing it to translocate to the nucleus and activate the transcription of its target genes, which are involved in cell proliferation and migration.",
            "biological_consequence": [
              "ATXN3 deubiquitinates YAP1 → Reduced YAP1 degradation → Increased YAP1 protein levels → Enhanced nuclear translocation and transcriptional activity → Upregulation of target genes (CTGF, CYR61) → Promotion of cancer cell proliferation and migration"
            ],
            "specific_effects": [
              "ATXN3 depletion decreases YAP1 protein levels and the expression of YAP/TEAD target genes.",
              "The Josephin domain of ATXN3 interacts with the WW domain of YAP.",
              "ATXN3 specifically inhibits K48-linked polyubiquitination of YAP1.",
              "The interaction and subsequent stabilization of YAP1 by ATXN3 is observed in multiple cancer types, including breast, pancreatic, and prostate cancer."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 deubiquitinates YAP1 to promote tumor growth",
                "year": 2021
              },
              {
                "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
                "year": 2023
              },
              {
                "paper_title": "The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "HDAC3",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 cooperates with and directly regulates the ubiquitination state of Histone Deacetylase 3 (HDAC3), implicating it in transcriptional regulation and immune responses.",
        "functions": [
          {
            "function": "HDAC3 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with and deubiquitinates Histone Deacetylase 3 (HDAC3), protecting it from proteasomal degradation.",
            "effect_description": "By stabilizing HDAC3, ATXN3 enhances its protein levels, which is crucial for modulating cellular processes like the type I interferon (IFN-I) antiviral response.",
            "biological_consequence": [
              "ATXN3 deubiquitinates HDAC3 → Increased HDAC3 protein stability → Enhanced IFN-I signaling pathway → Potentiated antiviral response"
            ],
            "specific_effects": [
              "ATXN3 deubiquitinates both K48- and K63-linked ubiquitin chains on HDAC3.",
              "The interaction between ATXN3 and HDAC3 increases during viral infection.",
              "Overexpression of ATXN3 upregulates HDAC3 protein levels, while ATXN3 knockout down-regulates them."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3",
                "year": 2018
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          },
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "Wild-type ATXN3 recruits HDAC3 to specific gene promoters, such as the MMP-2 promoter, leading to histone deacetylation and transcriptional repression.",
            "effect_description": "This interaction forms a repressor complex that silences gene expression. ATXN3's role in this context is to facilitate the enzymatic activity of HDAC3 on chromatin.",
            "biological_consequence": [
              "ATXN3 binds target promoter → Recruits HDAC3/NCoR complex → Histone deacetylation at promoter → Chromatin condensation → Repression of gene transcription (e.g., MMP-2)"
            ],
            "specific_effects": [
              "Normal ATXN3 cooperates with HDAC3 to repress transcription, a function requiring its ubiquitin-interacting motifs (UIMs).",
              "PolyQ-expanded ATXN3 fails to properly recruit HDAC3, leading to a loss of repressor function and aberrant gene expression.",
              "ATXN3 and HDAC3 cooperate to regulate chromatin organization, a function that is independent of ATXN3's catalytic activity."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "year": 2008
              },
              {
                "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
                "year": 2018
              },
              {
                "paper_title": "ATXN3 controls DNA replication and transcription by regulating chromatin structure",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "CREBBP",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 is known to interact and cooperate with the transcriptional co-activator CREB-binding protein (CREBBP or CBP), suggesting a direct role in transcriptional regulation.",
        "functions": [
          {
            "function": "CREBBP/p300 Histone Acetyltransferase (HAT) Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly interacts with the transcriptional co-activators CREBBP (CBP) and EP300 (p300), which possess histone acetyltransferase (HAT) activity.",
            "effect_description": "Through this interaction, ATXN3 acts as a transcriptional repressor by inhibiting the HAT activity of the CBP/p300 complex, thereby preventing histone acetylation and gene activation.",
            "biological_consequence": [
              "ATXN3 binds to CREBBP/p300 → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression"
            ],
            "specific_effects": [
              "The C-terminal domain of ATXN3 binds to CREBBP and p300.",
              "ATXN3 is known to cooperate with numerous transcriptional regulators including CBP and p300 to control transcription."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "year": 2008
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "EP300",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with the transcriptional co-activator p300 (EP300), indicating its involvement in the regulation of gene expression through chromatin modification.",
        "functions": [
          {
            "function": "CREBBP/p300 Histone Acetyltransferase (HAT) Activity",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 directly interacts with the transcriptional co-activators EP300 (p300) and CREBBP (CBP), which possess histone acetyltransferase (HAT) activity.",
            "effect_description": "This interaction allows ATXN3 to function as a transcriptional repressor by inhibiting the HAT activity of the p300/CBP complex, which in turn prevents histone acetylation required for gene activation.",
            "biological_consequence": [
              "ATXN3 binds to EP300/CREBBP → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression"
            ],
            "specific_effects": [
              "The C-terminal domain of ATXN3 binds to p300 and CREBBP.",
              "ATXN3 is part of a network of transcriptional regulators that includes p300 and CBP."
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation",
                "year": 2008
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "KEAP1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 regulates the stability of Kelch-like ECH-associated protein 1 (KEAP1) by slowing its proteasomal degradation, suggesting a direct deubiquitinase-substrate relationship.",
        "functions": [
          {
            "function": "KEAP1 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 regulates the turnover of KEAP1, a substrate adaptor for the CUL3 E3 ubiquitin ligase complex that targets NRF2 for degradation.",
            "effect_description": "ATXN3 promotes the stability of KEAP1 by slowing its degradation, thereby maintaining the repression of the NRF2-mediated antioxidant response under basal conditions.",
            "biological_consequence": [
              "ATXN3 stabilizes KEAP1 → Maintained KEAP1 levels → Constitutive ubiquitination and degradation of NRF2 → Repression of antioxidant gene expression"
            ],
            "specific_effects": [
              "Depletion of ATXN3 leads to destabilization and a decreased half-life of the KEAP1 protein.",
              "Loss of ATXN3 and the subsequent decrease in KEAP1 levels result in an increase of NRF2 and p62/SQSTM1."
            ],
            "evidence": [
              {
                "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
                "year": 2021
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "BCL2",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly regulates the autophagy inhibitor B-cell lymphoma 2 (BCL2) by modulating the E3 ligase activity of Parkin, which in turn ubiquitinates BCL2.",
        "functions": [
          {
            "function": "BCL2 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 modulates the E3 ligase activity of Parkin (PARK2). Functional PARK2 directly interacts with and mono-ubiquitinates the anti-apoptotic and autophagy-inhibitory protein BCL2.",
            "effect_description": "This mono-ubiquitination by PARK2 stabilizes BCL2 and increases its steady-state protein levels. By regulating PARK2, ATXN3 indirectly controls the stability of BCL2, a key regulator of apoptosis and autophagy.",
            "biological_consequence": [
              "ATXN3 regulates PARK2 activity → PARK2 mono-ubiquitinates BCL2 → Increased BCL2 protein stability → Enhanced inhibition of autophagy and apoptosis"
            ],
            "specific_effects": [
              "PARK2 directly binds to BCL2 and mediates its mono-ubiquitination.",
              "The mono-ubiquitination of BCL2 by PARK2 increases its protein level.",
              "By stabilizing BCL2, PARK2 enhances the interaction between BCL2 and the autophagy initiator Beclin 1, thereby inhibiting autophagy."
            ],
            "evidence": [
              {
                "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
                "year": 2010
              },
              {
                "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
                "year": 2012
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "PARK2",
              "chain": [
                "PARK2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "SOD2",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly regulates the expression of Superoxide Dismutase 2 (SOD2) by modulating the activity of the transcription factor FOXO4, which controls the antioxidant stress response.",
        "functions": [
          {
            "function": "SOD2 Gene Transcription",
            "arrow": "activates",
            "cellular_process": "ATXN3 functions as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, both ATXN3 and FOXO4 translocate to the nucleus, where they coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.",
            "effect_description": "By enhancing the FOXO4-dependent transcription of SOD2, ATXN3 indirectly boosts the expression of this critical mitochondrial antioxidant enzyme, which is essential for clearing superoxide radicals.",
            "biological_consequence": [
              "Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-activation of SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced scavenging of mitochondrial reactive oxygen species (ROS)"
            ],
            "specific_effects": [
              "The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.",
              "Knockdown of ATXN3 represses the expression of SOD2.",
              "Mutant ATXN3 has a reduced capacity to activate FOXO4-mediated SOD2 expression."
            ],
            "evidence": [
              {
                "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
                "year": 2011
              },
              {
                "paper_title": "Redox regulation of FoxO transcription factors",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "FOXO4",
              "chain": [
                "FOXO4"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "BAX",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly upregulates the mRNA expression of the pro-apoptotic protein BAX by enhancing the transcriptional activity of p53, which it directly stabilizes.",
        "functions": [
          {
            "function": "Apoptosis",
            "arrow": "activates",
            "cellular_process": "ATXN3 indirectly promotes the expression of the pro-apoptotic protein BAX. This occurs through the direct stabilization and activation of the transcription factor p53, which in turn transcriptionally upregulates its target gene, BAX.",
            "effect_description": "By increasing p53 stability, ATXN3 enhances the p53-mediated apoptotic pathway. PolyQ-expanded ATXN3 shows an even stronger ability to stabilize p53, leading to heightened p53-dependent apoptosis, which contributes to neurodegeneration.",
            "biological_consequence": [
              "ATXN3 stabilizes TP53 -> Increased TP53 transcriptional activity -> Upregulation of BAX mRNA expression -> Increased BAX protein levels -> Promotion of apoptosis"
            ],
            "specific_effects": [
              "p53 promotes neuronal apoptosis by enhancing the transcription of proapoptotic genes including Bax.",
              "Mutant ATXN3 increases p53 stability, leading to increased p53-dependent apoptosis."
            ],
            "evidence": [
              {
                "paper_title": "Tissue-specific vulnerability to apoptosis in Machado-Joseph disease",
                "year": 2023
              },
              {
                "paper_title": "Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons",
                "year": 2010
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "TP53",
              "chain": [
                "TP53"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "FOXO4",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with the transcription factor FOXO4, and upon oxidative stress, they translocate to the nucleus together to activate the transcription of the SOD2 gene.",
        "functions": [
          {
            "function": "Antioxidant Gene Transcription",
            "arrow": "activates",
            "cellular_process": "Under conditions of oxidative stress, ATXN3 interacts with the transcription factor FOXO4. Both proteins translocate to the nucleus and coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.",
            "effect_description": "This co-activation enhances the FOXO4-dependent transcription of SOD2, a key antioxidant enzyme, thereby promoting cellular defense against reactive oxygen species (ROS).",
            "biological_consequence": [
              "Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-binding to SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced clearance of ROS → Cellular protection"
            ],
            "specific_effects": [
              "The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.",
              "Knockdown of ATXN3 represses the expression of SOD2.",
              "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression and interferes with FOXO4 binding to the SOD2 promoter."
            ],
            "evidence": [
              {
                "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
                "year": 2011
              },
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              },
              {
                "paper_title": "Redox regulation of FoxO transcription factors",
                "year": 2015
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "NRF2",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 is thought to deubiquitinate and stabilize the transcription factor NRF2 (NFE2L2), a master regulator of the antioxidant response, which is a function analogous to other deubiquitinases like DUB3.",
        "functions": [
          {
            "function": "Antioxidant Response Activation",
            "arrow": "activates",
            "cellular_process": "ATXN3 is proposed to regulate the NRF2 pathway, which controls the expression of antioxidant and detoxification enzymes. This likely occurs through the deubiquitination and stabilization of NRF2, preventing its KEAP1-mediated degradation.",
            "effect_description": "By stabilizing NRF2, ATXN3 would promote its nuclear translocation and subsequent activation of Antioxidant Response Element (ARE)-containing genes, enhancing the cell's capacity to counteract oxidative stress.",
            "biological_consequence": [
              "ATXN3 deubiquitinates NRF2 → NRF2 escapes KEAP1-mediated degradation → NRF2 accumulates and translocates to nucleus → Binds to ARE sequences → Transcription of antioxidant genes (e.g., HO-1, NQO1)"
            ],
            "specific_effects": [
              "NRF2 is a master regulator of the antioxidant response, and its stability is tightly controlled by KEAP1-mediated ubiquitination.",
              "Activation of the NRF2 pathway is a key cellular defense against oxidative stress."
            ],
            "evidence": [
              {
                "paper_title": "The complexity of the Nrf2 pathway: Beyond the antioxidant response",
                "year": 2015
              },
              {
                "paper_title": "The effect of ATX through Nrf2 pathway on different disorders.",
                "year": 2023
              },
              {
                "paper_title": "Activation of NRF2 and FXN in Friedreich Ataxia",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "TRAF6",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 is known to deubiquitinate TNF receptor-associated factor 6 (TRAF6), thereby modulating immune signaling pathways.",
        "functions": [
          {
            "function": "NF-κB and MAPK Signaling",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 acts as a deubiquitinase for TRAF6, an E3 ubiquitin ligase crucial for activating downstream signaling pathways like NF-κB and MAPK upon stimulation of receptors such as TLRs and TNFRs.",
            "effect_description": "By cleaving polyubiquitin chains from TRAF6, ATXN3 negatively regulates its signaling activity, thereby dampening the inflammatory response.",
            "biological_consequence": [
              "ATXN3 deubiquitinates TRAF6 → Reduced TRAF6-mediated signaling → Decreased activation of IKK complex and MAPKs → Attenuated NF-κB and AP-1 activation → Downregulation of inflammatory gene expression"
            ],
            "specific_effects": [],
            "evidence": [
              {
                "paper_title": "CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "LC3",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 contains conserved LIR domains that directly interact with the autophagy adaptors LC3C and GABARAP, localizing to early autophagosomes in a transient regulatory interaction.",
        "functions": [
          {
            "function": "Autophagosome Association",
            "arrow": "activates",
            "cellular_process": "ATXN3 contains LC3-interacting region (LIR) motifs that allow it to directly bind to members of the Atg8 protein family, such as LC3 and GABARAP, which are localized on autophagosomal membranes.",
            "effect_description": "This interaction recruits ATXN3 to autophagosomes, suggesting a role in regulating the autophagic process, potentially by deubiquitinating substrates at the site of degradation or influencing autophagosome maturation.",
            "biological_consequence": [
              "ATXN3 binds to LC3/GABARAP via LIR motif → Recruitment of ATXN3 to autophagosome membrane → Modulation of local ubiquitination events → Regulation of autophagic flux"
            ],
            "specific_effects": [
              "LIR motifs are short linear sequences that mediate binding to Atg8-family proteins.",
              "Proteins containing LIR motifs are recruited to LC3/GABARAP through hydrophobic interactions.",
              "UIM-containing proteins, including ATXN3, have been shown to interact with both LC3 and GABARAP subfamilies."
            ],
            "evidence": [
              {
                "paper_title": "Semisynthetic LC3 Probes for Autophagy Pathways Reveal a Noncanonical LC3 Interacting Region Motif Crucial for the Enzymatic Activity of Human ATG3",
                "year": 2020
              },
              {
                "paper_title": "The rapidly expanding role of LC3-interacting regions in autophagy",
                "year": 2024
              },
              {
                "paper_title": "Atg8-Family Proteins—Structural Features and Molecular Interactions in Autophagy and Beyond",
                "year": 2020
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PML",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with the Promyelocytic leukemia (PML) protein, and expression of mutant ATXN3 alters the normal nuclear distribution of PML.",
        "functions": [
          {
            "function": "PML Nuclear Body Organization",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 interacts with the Promyelocytic leukemia (PML) protein, a key component of PML nuclear bodies, which are subnuclear structures involved in various cellular processes like transcription, DNA repair, and apoptosis.",
            "effect_description": "The expression of polyQ-expanded ATXN3 disrupts the normal structure and distribution of PML nuclear bodies, which may contribute to the transcriptional dysregulation and cellular stress seen in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 interacts with PML → Sequestration or mislocalization of PML protein → Disruption of PML nuclear body integrity → Impaired PML-dependent cellular functions"
            ],
            "specific_effects": [
              "Expression of certain PML isoforms (e.g., PML IV) can promote the degradation of soluble polyQ proteins, a protective mechanism that is disrupted when PML is mislocalized. [4]",
              "The sequestration of PML by mutant ATXN3 can impair the DNA damage response (DDR) and other PML-NB-associated functions. [7]"
            ],
            "evidence": [
              {
                "paper_title": "PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins",
                "year": 2007
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "SP1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 can act as a transcriptional co-repressor by interacting with the transcription factor SP1.",
        "functions": [
          {
            "function": "Transcriptional Repression",
            "arrow": "activates",
            "cellular_process": "ATXN3 is known to interact with the transcription factor SP1, acting as a co-repressor to regulate gene expression.",
            "effect_description": "This interaction contributes to the silencing of specific gene promoters, although the precise mechanism and full range of target genes are not fully detailed.",
            "biological_consequence": [
              "ATXN3 binds SP1 on chromatin -> Recruitment of repressor complexes -> Transcriptional silencing"
            ],
            "specific_effects": [
              "Normal ATXN3 binds to the promoter of the MMP-2 gene and represses its transcription by recruiting a complex containing HDAC3 and NCoR. [9, 10]",
              "PolyQ-expanded ATXN3 loses this repressor function, leading to aberrant MMP-2 transcription. [9, 19]"
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
                "year": 2008
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "HSP70",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with Heat Shock Protein 70 (HSP70), specifically Hsc70-4 in Drosophila, via its UIMs, which enhances aggregation and toxicity.",
        "functions": [
          {
            "function": "ATXN3 Aggregation",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly interacts with Heat Shock Protein 70 (HSP70/HSPA) chaperones through its ubiquitin-interacting motifs (UIMs).",
            "effect_description": "This interaction, particularly with polyQ-expanded ATXN3, is thought to be a critical step in the formation of protein aggregates, as chaperones are recruited to misfolded proteins. This can paradoxically enhance aggregation and cellular toxicity.",
            "biological_consequence": [
              "Misfolded polyQ-ATXN3 binds HSP70 -> Sequestration of chaperones into aggregates -> Impaired protein quality control -> Enhanced aggregation and toxicity"
            ],
            "specific_effects": [
              "HSP70 is a common component of the neuronal intranuclear inclusions found in SCA3."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "HSP40",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "The co-chaperone HSP40 (DNAJ) is recruited to and localizes within the intranuclear inclusions formed by mutant ATXN3, working alongside HSP70.",
        "functions": [
          {
            "function": "ATXN3 Aggregation",
            "arrow": "activates",
            "cellular_process": "The co-chaperone HSP40 (DNAJ family) is recruited to and co-localizes with aggregates formed by polyQ-expanded ATXN3, working in concert with HSP70.",
            "effect_description": "HSP40 acts as a co-chaperone that typically presents misfolded substrates to HSP70. Its presence within ATXN3 inclusions indicates its involvement in the cellular response to misfolded ATXN3, contributing to the aggregation process.",
            "biological_consequence": [
              "Misfolded polyQ-ATXN3 recruits HSP40/HSP70 complex -> Sequestration of chaperone machinery -> Formation of stable intranuclear inclusions -> Cellular toxicity"
            ],
            "specific_effects": [
              "HSP40 is found within the neuronal intranuclear inclusions characteristic of SCA3."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "UBQLN1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "Ubiquilin-1 (UBQLN1) is reported to interact with ATXN3 and is involved in protein degradation pathways and aggresome formation.",
        "functions": [
          {
            "function": "Protein Degradation & Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with Ubiquilin-1 (UBQLN1), a protein that links the ubiquitination machinery to the proteasome and is also involved in aggresome formation.",
            "effect_description": "This interaction suggests a cooperative role in managing protein quality control, where both proteins are involved in recognizing and processing ubiquitinated substrates for either degradation or sequestration into aggresomes.",
            "biological_consequence": [
              "ATXN3 and UBQLN1 co-recognize ubiquitinated substrates -> Facilitated delivery to proteasome or aggresome pathway -> Clearance of misfolded proteins"
            ],
            "specific_effects": [
              "UBQLN1 is a component of the cellular machinery for clearing aggregation-prone proteins."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "UBQLN2",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "Co-immunoprecipitation studies and analysis of human and mouse brain tissue show that UBQLN2 does not interact with either normal or polyQ-expanded ATXN3. Unlike in Huntington's disease where UBQLN2 is recruited to aggregates, it is absent from ATXN3 inclusions in SCA3.",
        "functions": [
          {
            "function": "Protein Aggregation & Clearance",
            "arrow": "inhibits",
            "cellular_process": "In contrast to other polyglutamine diseases like Huntington's, UBQLN2, a key protein in the ubiquitin-proteasome pathway, does not interact with or co-localize to the protein aggregates formed by polyQ-expanded ATXN3.",
            "effect_description": "This lack of interaction suggests that ATXN3 is not a substrate for UBQLN2-mediated clearance, and the sequestration of protein quality control components by aggregates, a key feature in other neurodegenerative diseases, occurs differently in Spinocerebellar Ataxia Type 3.",
            "biological_consequence": [
              "PolyQ-ATXN3 aggregates form → UBQLN2 is not recruited → ATXN3 aggregates are not processed by UBQLN2-dependent pathways → Highlights a distinct pathomechanism for SCA3 compared to Huntington's disease"
            ],
            "specific_effects": [
              "Co-precipitation studies in cultured cells demonstrated that UBQLN2 fails to interact with normal or expanded ATXN3 protein.",
              "UBQLN2 is recruited to inclusions in Huntington's disease (HD) but not in Spinocerebellar Ataxia Type 3 (SCA3) mouse models and human brain tissue.",
              "The lack of co-localization suggests that components of neuronal protein quality control may be differentially perturbed in distinct polyQ diseases."
            ],
            "evidence": [
              {
                "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
                "year": 2015
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PSMC6",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 interacts with proteasome subunits, which are found within the neuronal intranuclear inclusions characteristic of SCA3.",
        "functions": [
          {
            "function": "Proteasomal Degradation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with subunits of the 26S proteasome, such as PSMC6 (Rpt4), a component of the 19S regulatory particle.",
            "effect_description": "This interaction places ATXN3 at the site of protein degradation, consistent with its role in processing ubiquitinated substrates before their entry into the proteasome. Proteasome components are also frequently found sequestered within the neuronal inclusions of SCA3.",
            "biological_consequence": [
              "ATXN3 binds to 19S proteasome cap -> Deubiquitinates substrates prior to degradation -> Regulation of protein turnover"
            ],
            "specific_effects": [
              "Proteasome subunits are often found within the intranuclear inclusions formed by mutant ATXN3."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "DYNC1H1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 acts as an adaptor to link polyubiquitinated substrates to the dynein motor protein complex to facilitate transport to the aggresome.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "ATXN3 interacts with the dynein motor complex, including the heavy chain DYNC1H1. It acts as an adaptor protein, linking polyubiquitinated protein aggregates to the dynein machinery.",
            "effect_description": "This function is crucial for the retrograde transport of misfolded protein aggregates along microtubules to the microtubule-organizing center (MTOC), where they coalesce to form a perinuclear aggresome.",
            "biological_consequence": [
              "ATXN3 binds ubiquitinated aggregate -> ATXN3 binds DYNC1H1 -> Dynein motor transports aggregate along microtubule -> Delivery to perinuclear aggresome"
            ],
            "specific_effects": [
              "This transport mechanism is dependent on both ATXN3 and HDAC6."
            ],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "HMOX1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly upregulates the expression of Heme Oxygenase 1 (HMOX1) by deubiquitinating and stabilizing the transcription factor NRF2, which then activates HMOX1 transcription.",
        "functions": [
          {
            "function": "HMOX1 Gene Transcription",
            "arrow": "activates",
            "cellular_process": "ATXN3 is proposed to deubiquitinate and stabilize the transcription factor NRF2. This stabilization allows NRF2 to accumulate and translocate to the nucleus, where it binds to the Antioxidant Response Element (ARE) located in the promoter of the Heme Oxygenase 1 (HMOX1) gene.",
            "effect_description": "By promoting the stability and transcriptional activity of NRF2, ATXN3 indirectly upregulates the expression of the cytoprotective enzyme HMOX1, a key component of the cellular defense against oxidative stress.",
            "biological_consequence": [
              "ATXN3 stabilizes NRF2 → NRF2 accumulates in the nucleus → NRF2 binds to the ARE in the HMOX1 promoter → Increased HMOX1 mRNA and protein expression → Heme degradation and production of antioxidant biliverdin/bilirubin"
            ],
            "specific_effects": [
              "HMOX1 is a well-established target gene of the NRF2 transcription factor.",
              "NRF2 activation is a prerequisite for HMOX1 induction in response to oxidative stress."
            ],
            "evidence": [
              {
                "paper_title": "Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1",
                "year": 2008
              },
              {
                "paper_title": "Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "NRF2",
              "chain": [
                "NRF2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "GCLM",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly enhances the expression of Glutamate-Cysteine Ligase Modifier Subunit (GCLM) by stabilizing its transcriptional activator, NRF2.",
        "functions": [
          {
            "function": "GCLM Gene Transcription & Glutathione Synthesis",
            "arrow": "activates",
            "cellular_process": "ATXN3 is thought to stabilize the transcription factor NRF2, promoting its nuclear translocation and activity. NRF2 then directly binds to the Antioxidant Response Element (ARE) in the promoter of the Glutamate-Cysteine Ligase Modifier Subunit (GCLM) gene, activating its transcription.",
            "effect_description": "By upregulating GCLM expression via NRF2, ATXN3 indirectly enhances the efficiency of glutamate-cysteine ligase, the rate-limiting enzyme in the synthesis of the major cellular antioxidant glutathione (GSH).",
            "biological_consequence": [
              "ATXN3 stabilizes NRF2 → NRF2 activates GCLM transcription → Increased GCLM protein levels → Enhanced GCL enzyme activity → Increased synthesis of glutathione (GSH) → Improved cellular detoxification and antioxidant capacity"
            ],
            "specific_effects": [
              "NRF2 governs the basal and inducible expression of both GCLC and GCLM subunits of glutamate-cysteine ligase.",
              "A decline in NRF2 transcriptional activity is linked to an age-related loss of glutathione synthesis."
            ],
            "evidence": [
              {
                "paper_title": "Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid",
                "year": 2004
              },
              {
                "paper_title": "Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo",
                "year": 2008
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "NRF2",
              "chain": [
                "NRF2"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "SQSTM1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3, playing a role in the formation of aggresomes and protecting cells from cell death.",
        "functions": [
          {
            "function": "Aggresome Formation",
            "arrow": "activates",
            "cellular_process": "The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3. This interaction is crucial for the sequestration of misfolded ATXN3 into larger inclusion bodies.",
            "effect_description": "p62 acts as a scaffold protein that recognizes and binds ubiquitinated protein aggregates, facilitating their collection into aggresomes. This process is considered a protective cellular response to sequester toxic protein species.",
            "biological_consequence": [
              "PolyQ-ATXN3 aggregates form -> SQSTM1 binds to aggregates -> Facilitates coalescence into a single aggresome -> Sequestration of toxic protein -> Cellular protection"
            ],
            "specific_effects": [
              "p62 directly interacts with pathogenic ataxin-3 but not normal ataxin-3.",
              "The interaction is dependent on microtubules.",
              "p62 protects cells against polyQ-expanded ataxin-3-induced cell death."
            ],
            "evidence": [
              {
                "paper_title": "p62/sequestosome 1 regulates aggresome formation of pathogenic ataxin-3 with expanded polyglutamine",
                "year": 2014
              },
              {
                "paper_title": "p62, the Receptor for Selective Autophagy, Contributes in ATXN3 Aggregate Formation in Spinocerebellar Ataxia Type 3",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "SUMO1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 is covalently modified by Small Ubiquitin-like Modifier 1 (SUMO-1), a process known as SUMOylation. This direct interaction was identified by yeast two-hybrid and confirmed by co-immunoprecipitation, and it is thought to regulate the biological function of ATXN3.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "ATXN3 is post-translationally modified by covalent attachment of Small Ubiquitin-like Modifier 1 (SUMO-1). This process, known as SUMOylation, is catalyzed by a cascade of E1, E2 (UBC9), and E3 (e.g., PIAS1) enzymes.",
            "effect_description": "SUMOylation of ATXN3, particularly at lysine 166, enhances its protein stability by competing with ubiquitination and preventing its degradation by the proteasome.",
            "biological_consequence": [
              "SUMO1 is conjugated to ATXN3 -> Prevents ubiquitin chain attachment -> Reduced proteasomal degradation -> Increased ATXN3 protein stability"
            ],
            "specific_effects": [
              "SUMO modification at K166 of polyQ-expanded ATXN3 enhances its stability."
            ],
            "evidence": [
              {
                "paper_title": "PIAS1 promotes ATXN3 SUMOylation and enhances its protein stability",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PIAS1",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "The SUMO E3 ligase PIAS1 directly interacts with ATXN3 to promote its SUMOylation. This interaction stabilizes ATXN3 by preventing its proteasome-mediated degradation.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "The SUMO E3 ligase PIAS1 directly interacts with ATXN3 and promotes its conjugation with SUMO proteins.",
            "effect_description": "By catalyzing the SUMOylation of ATXN3, PIAS1 increases the stability of both wild-type and polyQ-expanded ATXN3, protecting it from proteasome-mediated degradation.",
            "biological_consequence": [
              "PIAS1 binds ATXN3 -> Catalyzes SUMO attachment -> Reduced ATXN3 ubiquitination -> Increased ATXN3 protein levels"
            ],
            "specific_effects": [
              "PIAS1 knockdown leads to a dose-dependent decrease in both wild-type and mutant ATXN3 protein levels.",
              "The stabilization of ATXN3 by PIAS1 is prevented by treatment with the proteasome inhibitor MG132."
            ],
            "evidence": [
              {
                "paper_title": "PIAS1 S510G variant acts as a genetic modifier of spinocerebellar ataxia type 3 by selectively impairing mutant ataxin-3 proteostasis",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "UBC9",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "As the primary E2 SUMO-conjugating enzyme, UBC9 is a necessary and direct interactor for the SUMOylation of ATXN3, working in concert with E3 ligases like PIAS1.",
        "functions": [
          {
            "function": "ATXN3 SUMOylation",
            "arrow": "activates",
            "cellular_process": "UBC9 is the essential E2 SUMO-conjugating enzyme that directly interacts with ATXN3 and transfers the activated SUMO moiety to it, a process facilitated by an E3 ligase like PIAS1.",
            "effect_description": "As the sole E2 enzyme for SUMOylation, UBC9 is indispensable for the covalent modification of ATXN3 with SUMO, which in turn regulates ATXN3's stability and function.",
            "biological_consequence": [
              "Activated SUMO is transferred to UBC9 -> UBC9/PIAS1/ATXN3 form a complex -> SUMO is covalently attached to ATXN3 -> ATXN3 stability is enhanced"
            ],
            "specific_effects": [
              "The SUMOylation pathway involves the sequential action of E1, E2 (UBC9), and E3 enzymes."
            ],
            "evidence": [
              {
                "paper_title": "Conserved residues within PIAS1 and UBC9 play a key role in the...",
                "year": 2024
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "SRSF7",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly interacts with and deubiquitinates the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), thereby regulating its stability and influencing mRNA splicing processes, including that of the MAPT (Tau) gene.",
        "functions": [
          {
            "function": "mRNA Splicing",
            "arrow": "activates",
            "cellular_process": "ATXN3 functions as a deubiquitinase for the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), removing polyubiquitin chains to regulate its stability and activity.",
            "effect_description": "By stabilizing SRSF7, ATXN3 influences the alternative splicing of various target mRNAs. A notable target is MAPT (Tau), where ATXN3 loss leads to a decreased 4R/3R-Tau ratio, linking ATXN3 function to another key protein in neurodegeneration.",
            "biological_consequence": [
              "ATXN3 deubiquitinates SRSF7 -> SRSF7 is stabilized -> Altered alternative splicing of target genes (e.g., MAPT) -> Changes in protein isoform ratios"
            ],
            "specific_effects": [
              "Loss of ATXN3 leads to altered polyubiquitylation of multiple proteins involved in RNA metabolism.",
              "Loss of ATXN3 deregulates MAPT exon 10 splicing."
            ],
            "evidence": [
              {
                "paper_title": "Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "TUBB",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 directly binds to tubulin with high affinity (around 50nM). This interaction is crucial for the microtubule-dependent transport of protein aggregates to the aggresome.",
        "functions": [
          {
            "function": "Microtubule-Dependent Aggregate Transport",
            "arrow": "activates",
            "cellular_process": "ATXN3 directly binds to tubulin, the main component of microtubules, with high affinity.",
            "effect_description": "This interaction is essential for linking protein aggregates to the microtubule network, enabling their transport by motor proteins like dynein to the aggresome. This function is a key part of the cellular response to misfolded protein stress.",
            "biological_consequence": [
              "ATXN3 binds aggregate -> ATXN3 binds tubulin/microtubules -> Aggregate is trafficked along microtubule network -> Sequestration in the aggresome"
            ],
            "specific_effects": [],
            "evidence": [
              {
                "paper_title": "The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation",
                "year": 2011
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "KLF4",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 functions as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), indicating a direct enzyme-substrate interaction that regulates KLF4 stability.",
        "functions": [
          {
            "function": "KLF4 Protein Stability",
            "arrow": "activates",
            "cellular_process": "ATXN3 acts as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), directly binding to it and removing polyubiquitin chains.",
            "effect_description": "By preventing its proteasomal degradation, ATXN3 stabilizes and increases the protein levels of KLF4. In the context of breast cancer, this stabilization promotes cancer cell metastasis.",
            "biological_consequence": [
              "ATXN3 deubiquitinates KLF4 -> KLF4 protein is stabilized -> Increased KLF4 levels -> Promotion of breast cancer metastasis"
            ],
            "specific_effects": [
              "ATXN3 was identified as a KLF4 deubiquitinase from a screen of 65 DUBs.",
              "High expression of both ATXN3 and KLF4 is associated with a poor prognosis in breast cancer patients."
            ],
            "evidence": [
              {
                "paper_title": "ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4",
                "year": 2019
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PJA1",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "The E3 ubiquitin ligase PJA1 (also known as RING finger protein 127) directly interacts with ATXN3 to promote its ubiquitination and subsequent degradation by both the proteasome and autophagy.",
        "functions": [
          {
            "function": "ATXN3 Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "The E3 ubiquitin ligase PJA1 (Praja1) interacts with and ubiquitinates ATXN3, targeting it for degradation.",
            "effect_description": "PJA1 promotes the degradation of both wild-type and polyQ-expanded ATXN3 through both the proteasome and autophagy pathways, thereby reducing ATXN3 protein levels and suppressing aggregate formation.",
            "biological_consequence": [
              "PJA1 ubiquitinates ATXN3 -> ATXN3 is targeted for degradation -> Reduced ATXN3 protein levels and aggregation -> Suppression of polyQ toxicity"
            ],
            "specific_effects": [
              "PJA1 expression is diminished when polyQ-expanded proteins are expressed.",
              "PJA1 promotes ATXN3 degradation by both the proteasome and autophagy."
            ],
            "evidence": [
              {
                "paper_title": "Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity",
                "year": 2018
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "AMFR",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "The E3 ubiquitin ligase AMFR (also known as Gp78) directly polyubiquitinates ATXN3, targeting it for degradation through the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway.",
        "functions": [
          {
            "function": "ATXN3 Protein Stability",
            "arrow": "inhibits",
            "cellular_process": "The E3 ubiquitin ligase AMFR (gp78), an enzyme involved in Endoplasmic Reticulum-Associated Degradation (ERAD), directly interacts with and polyubiquitinates ATXN3.",
            "effect_description": "This ubiquitination by AMFR targets ATXN3 for degradation via the ERAD pathway, playing a role in the quality control and turnover of ATXN3.",
            "biological_consequence": [
              "AMFR ubiquitinates ATXN3 -> ATXN3 is targeted to the ERAD pathway -> Proteasomal degradation of ATXN3"
            ],
            "specific_effects": [
              "Overexpression of gp78 promotes the ubiquitination and degradation of ATXN3.",
              "Knockdown of gp78 stabilizes ATXN3 protein."
            ],
            "evidence": [
              {
                "paper_title": "Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation",
                "year": 2009
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "CAMK2A",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "Proteomic analysis of ATXN3 pull-downs from mouse brain tissue revealed that mutant ATXN3 abnormally interacts with Calcium/calmodulin-dependent protein kinase II subunit alpha (Camk2a), a component of large protein complexes.",
        "functions": [
          {
            "function": "Protein Complex Formation",
            "arrow": "activates",
            "cellular_process": "Proteomic analysis of brain lysates from a SCA3 mouse model revealed that mutant, polyQ-expanded ATXN3 abnormally interacts with Camk2a, a subunit of the Calcium/calmodulin-dependent protein kinase II complex.",
            "effect_description": "This abnormal interaction suggests that mutant ATXN3 can sequester key neuronal proteins into large, insoluble complexes or aggregates, potentially disrupting their normal functions, such as mitochondrial transport in axons.",
            "biological_consequence": [
              "Mutant ATXN3 binds CAMK2A -> Sequestration into large protein complexes/aggregates -> Disruption of normal CAMK2A function (e.g., synaptic plasticity, transport)"
            ],
            "specific_effects": [
              "Mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5, Cct6, Tcp1, Camk2a and Camk2b."
            ],
            "evidence": [
              {
                "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
                "year": 2023
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "PTEN",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 is suggested to directly regulate the tumor suppressor PTEN, with evidence pointing to a deubiquitinase-substrate relationship that inhibits PTEN's anti-oncogene function in certain cancers.",
        "functions": [
          {
            "function": "PTEN Transcription",
            "arrow": "inhibits",
            "cellular_process": "ATXN3 acts as a transcriptional repressor of the tumor suppressor gene PTEN. This regulation is independent of ATXN3's deubiquitinase activity on the PTEN protein itself.",
            "effect_description": "By repressing PTEN transcription, ATXN3 can contribute to the hyperactivation of the PI3K/Akt signaling pathway, which is a common event in cancer. Depletion of ATXN3 leads to increased PTEN mRNA levels.",
            "biological_consequence": [
              "ATXN3 represses PTEN promoter -> Decreased PTEN mRNA and protein -> Reduced antagonism of PI3K pathway -> Increased Akt phosphorylation and signaling"
            ],
            "specific_effects": [
              "Depletion of ATXN3 increases PTEN transcript abundance but does not alter PTEN protein stability.",
              "ATXN3 depletion is sufficient to downregulate Akt phosphorylation."
            ],
            "evidence": [
              {
                "paper_title": "The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells",
                "year": 2014
              },
              {
                "paper_title": "The equilibrium of tumor suppression: DUBs as active regulators of PTEN",
                "year": 2022
              }
            ],
            "_context": {
              "type": "direct",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "MBNL1",
        "direction": "bidirectional",
        "arrow": "inhibits",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly affects the splicing factor Muscleblind-like Splicing Regulator 1 (MBNL1). The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms hairpin structures that sequester MBNL1 into nuclear foci, leading to its functional inactivation and subsequent misregulation of alternative splicing.",
        "functions": [
          {
            "function": "MBNL1 Splicing Activity",
            "arrow": "inhibits",
            "cellular_process": "The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms toxic hairpin structures in the nucleus. These RNA structures act as a scaffold to sequester the Muscleblind-like Splicing Regulator 1 (MBNL1).",
            "effect_description": "This sequestration leads to the functional inactivation of MBNL1, preventing it from regulating the alternative splicing of its target pre-mRNAs. This loss-of-function mechanism contributes to the spliceopathy observed in SCA3.",
            "biological_consequence": [
              "Mutant ATXN3 gene is transcribed into toxic RNA -> RNA hairpins sequester MBNL1 into nuclear foci -> MBNL1 is functionally depleted -> Misregulation of alternative splicing -> Cellular dysfunction"
            ],
            "specific_effects": [
              "The sequestration of MBNL1 into nuclear RNA foci by expanded CAG repeats is a shared pathomechanism with myotonic dystrophy type 1. [3, 28]"
            ],
            "evidence": [
              {
                "paper_title": "Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies",
                "year": 2015
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": null,
              "chain": null
            },
            "interaction_effect": "inhibits",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      },
      {
        "primary": "MAPT",
        "direction": "bidirectional",
        "arrow": "activates",
        "intent": "regulation",
        "support_summary": "ATXN3 indirectly regulates the alternative splicing of Microtubule-Associated Protein Tau (MAPT) by controlling the stability of the splicing factor SRSF7.",
        "functions": [
          {
            "function": "MAPT (Tau) Alternative Splicing",
            "arrow": "activates",
            "cellular_process": "ATXN3 deubiquitinates and stabilizes the splicing factor SRSF7. SRSF7 is a key regulator of MAPT (Tau) exon 10 splicing, which determines the ratio of 4-repeat (4R) to 3-repeat (3R) Tau isoforms.",
            "effect_description": "By maintaining SRSF7 levels, wild-type ATXN3 ensures the proper 4R/3R-Tau ratio. Loss of ATXN3 function, or its dysfunction in SCA3, leads to reduced SRSF7 levels and a decreased 4R/3R-Tau ratio, linking SCA3 pathology to tauopathy.",
            "biological_consequence": [
              "ATXN3 stabilizes SRSF7 → Proper regulation of MAPT exon 10 splicing → Maintained 4R/3R-Tau ratio → Normal neuronal function"
            ],
            "specific_effects": [
              "Loss of ATXN3 function leads to a decreased 4R/3R-Tau ratio.",
              "Similar splicing alterations are observed in cellular models of SCA3 and in patient brains."
            ],
            "evidence": [
              {
                "paper_title": "Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors",
                "year": 2019
              }
            ],
            "_context": {
              "type": "indirect",
              "query_protein": "SRSF7",
              "chain": [
                "SRSF7"
              ]
            },
            "interaction_effect": "activates",
            "direction": "main_to_primary",
            "interaction_direction": "main_to_primary"
          }
        ]
      }
    ]
  },
  "ndjson": [
    "{\"main\":\"ATXN3\",\"primary\":\"VCP\",\"direction\":\"bidirectional\",\"arrow\":\"regulates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with VCP/p97, an AAA+ ATPase involved in protein quality control, via a VCP binding motif (VBM) on ATXN3. This interaction is crucial for processes like ER-associated degradation (ERAD).\",\"functions\":[{\"function\":\"ER-Associated Degradation (ERAD)\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 binds to VCP/p97 via its VCP-binding motif (VBM) and competes with other VCP cofactors like Ufd1. This interaction modulates the extraction of ubiquitinated substrates from the endoplasmic reticulum.\",\"biological_consequence\":[\"ATXN3 binding to VCP → Sequesters VCP from other cofactors (e.g., Ufd1/Npl4) → Decreased extraction of ERAD substrates → Accumulation of misfolded proteins in the ER → ER stress\"],\"specific_effects\":[\"ATXN3 and Ufd1 bind to VCP in a mutually exclusive manner.\",\"ATXN3 decreases the interaction of VCP with ubiquitylated proteins.\",\"Pathological polyQ expansion in ATXN3 enhances VCP binding, leading to greater impairment of ERAD.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates\",\"year\":2006},{\"paper_title\":\"The Machado-Joseph disease deubiquitylase ataxin-3 couples pulldown and deubiquitylation of ubiquitylated proteins\",\"year\":2020},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]},{\"function\":\"ATXN3 Deubiquitinase Activity\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"VCP/p97 binds to ATXN3 and presents ubiquitinated substrates to it, which allosterically activates the deubiquitinase (DUB) activity of wild-type ATXN3.\",\"biological_consequence\":[\"VCP presents substrate to ATXN3 → Allosteric activation of ATXN3 Josephin domain → Enhanced cleavage of polyubiquitin chains → Substrate stabilization or altered signaling\"],\"specific_effects\":[\"VCP/p97 specifically activates the DUB activity of wild-type ATXN3, but not polyQ-expanded ATXN3.\",\"This activation is crucial for processing substrates within the protein quality control system.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3\",\"year\":2012}]},{\"function\":\"Lysosome Regeneration\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"Following lysosomal membrane damage, ATXN3 and its partner VCP/p97 are recruited to a subset of recovering lysosomes. There, they target and process K48-K63-branched ubiquitin chains on lysosomal proteins, such as LAMP2.\",\"biological_consequence\":[\"Lysosomal damage → ATXN3/VCP recruitment → Processing of branched ubiquitin chains on LAMP2 → LAMP2 degradation via microautophagy → Lysosomal membrane regeneration → Restoration of cellular degradative capacity\"],\"specific_effects\":[\"ATXN3 is required for lysophagic flux after lysosomal damage but not for the initial phagophore formation.\",\"The ATXN3-VCP complex specifically targets K48-K63-branched ubiquitin conjugates on regenerating lysosomes.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains\",\"year\":2025}]},{\"function\":\"PI3K Complex Assembly and Activity\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"VCP/p97 interacts with components of the class III PI3K complex, including BECN1 and ATG14. VCP stimulates the deubiquitinase activity of ATXN3, which in turn stabilizes BECN1.\",\"biological_consequence\":[\"VCP activates ATXN3 DUB activity → ATXN3 stabilizes BECN1 → VCP promotes PI3K complex assembly → Increased PtdIns3P production → Recruitment of early autophagy markers (WIPI2, ATG16L1) → Autophagy initiation\"],\"specific_effects\":[\"VCP's role in autophagy initiation is in addition to its known role in autophagosome maturation.\",\"Acute inhibition of VCP impairs PtdIns3P production and the recruitment of early autophagy machinery.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"VCP/p97 modulates PtdIns3P production and autophagy initiation\",\"year\":2021},{\"paper_title\":\"New functions of a known autophagy regulator: VCP and autophagy initiation\",\"year\":2021}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PARK2\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with and deubiquitinates the E3 ubiquitin ligase Parkin (PARK2), thereby regulating its activity. This interaction is implicated in pathways related to both protein degradation and neurodegenerative diseases like Parkinson's.\",\"functions\":[{\"function\":\"PARK2 Auto-ubiquitination\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PARK2) and removes ubiquitin chains from it, thereby counteracting its self-ubiquitination.\",\"biological_consequence\":[\"ATXN3 deubiquitinates PARK2 → Reduced PARK2 auto-ubiquitination → Altered PARK2 stability and activity → Modulation of mitophagy and substrate ubiquitination (e.g., Bcl-2).\"],\"specific_effects\":[\"ATXN3 counteracts Parkin self-ubiquitination in vitro and in cells.\",\"The interaction involves ATXN3 stabilizing the PARK2-E2 enzyme complex, which diverts ubiquitin transfer away from PARK2.\",\"Mutant ATXN3 promotes the clearance of PARK2 via the autophagy pathway.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme\",\"year\":2012},{\"paper_title\":\"The deubiquitinase ataxin-3 requires its two UIMs to suppress parkin-mediated parkinsonism\",\"year\":2008},{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]},{\"function\":\"Parkin Protein Stability\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"PolyQ-expanded ATXN3 enhances the deubiquitination of Parkin, with a preference for cleaving K27- and K29-linked ubiquitin chains that may protect Parkin from autophagic degradation.\",\"biological_consequence\":[\"Mutant ATXN3 deubiquitinates PARK2 (cleaves K27/K29 chains) → Increased PARK2 turnover → Enhanced autophagic degradation of PARK2 → Reduced PARK2 protein levels → Impaired mitophagy and mitochondrial quality control\"],\"specific_effects\":[\"This effect is specific to polyQ-expanded ATXN3 and leads to a reduction of Parkin levels in MJD mouse models.\",\"The loss of Parkin function is a primary cause of familial Parkinson's disease.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Mutant ataxin-3 promotes the autophagic degradation of parkin\",\"year\":2011},{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"HDAC6\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly binds to Histone Deacetylase 6 (HDAC6). This interaction is involved in the cellular machinery that sorts protein aggregates to the aggresome via microtubules.\",\"functions\":[{\"function\":\"Aggresome Formation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with HDAC6, a key component of the machinery that transports misfolded protein aggregates to the aggresome. ATXN3's DUB activity generates unanchored ubiquitin C-termini on aggregates, which are then recognized by the ubiquitin-binding domain of HDAC6.\",\"biological_consequence\":[\"ATXN3 trims ubiquitin chains on aggregates → Exposes ubiquitin C-termini → HDAC6 binds exposed C-termini → HDAC6 links aggregate to Dynein motor → Transport to aggresome\"],\"specific_effects\":[\"ATXN3, HDAC6, and dynein are part of a complex that has ubiquitin protease activity.\",\"Depletion of ATXN3 leads to decreased aggresome formation.\",\"HDAC6 recognizes and binds to unanchored C-terminal diglycine motifs of ubiquitin generated by ATXN3 on protein aggregates.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation\",\"year\":2011},{\"paper_title\":\"Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini\",\"year\":2012},{\"paper_title\":\"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress\",\"year\":2007}]},{\"function\":\"HDAC6 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with and deubiquitinates Histone Deacetylase 6 (HDAC6), protecting it from proteasomal degradation.\",\"biological_consequence\":[\"ATXN3 deubiquitinates HDAC6 → Reduced HDAC6 degradation → Increased HDAC6 protein levels → Enhanced downstream HDAC6 functions (e.g., cell migration)\"],\"specific_effects\":[\"In pancreatic cancer, high ATXN3 expression correlates with high HDAC6 levels and promotes cell proliferation, migration, and invasion.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6\",\"year\":2023}]},{\"function\":\"Actin-Dependent Cell Motility\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 stabilizes HDAC6, which in turn deacetylates the F-actin-binding protein cortactin. The acetylation status of cortactin modulates its ability to bind F-actin.\",\"biological_consequence\":[\"ATXN3 stabilizes HDAC6 → Increased HDAC6 activity → Deacetylation of cortactin → Altered cortactin-F-actin binding → Modulation of actin cytoskeleton → Enhanced cell motility\"],\"specific_effects\":[\"HDAC6 influences actin-dependent cell motility in addition to its role in microtubule-dependent transport.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin\",\"year\":2007}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"RAD23A\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with the proteasome-associated protein RAD23A (hHR23A), which is involved in delivering ubiquitinated substrates to the proteasome and also prevents the proteasomal degradation of ATXN3 itself.\",\"functions\":[{\"function\":\"Proteasome-Mediated Protein Degradation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with RAD23A (hHR23A), a shuttle protein that delivers ubiquitinated substrates to the 26S proteasome for degradation.\",\"biological_consequence\":[\"ATXN3 binds RAD23A → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome\"],\"specific_effects\":[\"ATXN3's interaction with Rad23 homologs suggests it can monitor proteasome traffic and the delivery of ubiquitylated proteins.\",\"The interaction between ATXN3 and RAD23A has been confirmed by co-immunoprecipitation.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A\",\"year\":1999},{\"paper_title\":\"Physiological and pathophysiological characteristics of ataxin-3 isoforms\",\"year\":2019}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"RAD23B\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which plays a similar role in the ubiquitin-proteasome system and in protecting ATXN3 from degradation.\",\"functions\":[{\"function\":\"Proteasome-Mediated Protein Degradation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with RAD23B (hHR23B), a homolog of RAD23A, which functions as a shuttle protein to deliver ubiquitinated substrates to the 26S proteasome.\",\"biological_consequence\":[\"ATXN3 binds RAD23B → Forms complex with ubiquitinated substrates → Facilitates substrate delivery to the proteasome\"],\"specific_effects\":[\"ATXN3's interaction with Rad23 homologs is implicated in its role in ERAD.\",\"The interaction between ATXN3 and RAD23B has been confirmed by co-immunoprecipitation.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3, the product of the MJD-1 gene, interacts with the ubiquitin- and proteasome-associated protein HHR23A\",\"year\":1999},{\"paper_title\":\"Physiological and pathophysiological characteristics of ataxin-3 isoforms\",\"year\":2019}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"STUB1\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with and deubiquitinates STUB1 (CHIP), an E3 ubiquitin ligase, thereby modulating its activity within the ubiquitin-proteasome system.\",\"functions\":[{\"function\":\"STUB1/CHIP Ubiquitination Activity\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with and deubiquitinates the E3 ubiquitin ligase STUB1 (CHIP), which is involved in the degradation of misfolded chaperone substrates.\",\"biological_consequence\":[\"ATXN3 deubiquitinates STUB1 → Limits polyubiquitin chain extension on STUB1 substrates → Modulates substrate degradation\"],\"specific_effects\":[\"ATXN3 is recruited to monoubiquitinated STUB1/CHIP.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"CHIP and ataxin-3 govern the assembly of pathogenic polyglutamine aggregates\",\"year\":2013},{\"paper_title\":\"Ataxin-3 is a CHIP-co-chaperone-associated DUB\",\"year\":2013}]},{\"function\":\"Chaperone-Mediated Substrate Degradation\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 collaborates with the E3 ligase STUB1/CHIP and chaperones (e.g., HSP70) in the degradation of misfolded substrates via pathways like chaperone-mediated autophagy (CMA) and the proteasome.\",\"biological_consequence\":[\"Misfolded substrate binds HSP70/CHIP complex → CHIP ubiquitinates substrate → ATXN3 trims polyubiquitin chains → Modulated signal for degradation (proteasome or CMA) → Altered substrate turnover\"],\"specific_effects\":[\"STUB1/CHIP is required for the CMA-mediated degradation of substrates like HIF1A.\",\"ATXN3 restricts the length of ubiquitin chains attached to STUB1/CHIP substrates, preventing further chain extension.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy\",\"year\":2013},{\"paper_title\":\"Co-Chaperone HSJ1a Dually Regulates the Proteasomal Degradation of Ataxin-3\",\"year\":2011}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"TP53\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly binds to and stabilizes the tumor suppressor p53 (TP53) by removing polyubiquitin chains, thereby preventing its degradation and promoting p53-mediated signaling.\",\"functions\":[{\"function\":\"TP53 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 acts as a deubiquitinase for the tumor suppressor p53 (TP53). It binds directly to both native and polyubiquitinated p53 and removes ubiquitin chains, protecting it from proteasomal degradation.\",\"biological_consequence\":[\"ATXN3 deubiquitinates TP53 → TP53 protein stabilization → Increased TP53 transcriptional activity → Enhanced p53-dependent apoptosis and cell cycle arrest.\"],\"specific_effects\":[\"ATXN3 deletion destabilizes p53, leading to reduced p53 activity.\",\"ATXN3 stabilizes p53 via the ubiquitin-proteasome pathway, not the lysosomal pathway.\",\"PolyQ-expanded ATXN3 has an enhanced ability to bind and deubiquitinate p53, leading to prolonged p53 signaling and increased apoptosis.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53\",\"year\":2015},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PNKP\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 forms a direct complex with Polynucleotide Kinase 3'-Phosphatase (PNKP) to promote its phosphatase activity, playing a role in DNA single-strand break repair.\",\"functions\":[{\"function\":\"DNA Strand Break Repair\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"Wild-type ATXN3 forms a complex with Polynucleotide Kinase 3'-Phosphatase (PNKP), a key enzyme in the repair of DNA single- and double-strand breaks. This interaction promotes PNKP's 3'-phosphatase activity.\",\"biological_consequence\":[\"ATXN3 binds PNKP → Promotes PNKP phosphatase activity → Efficient processing of 3'-phosphate termini at DNA breaks → Facilitates DNA single-strand and double-strand break repair.\"],\"specific_effects\":[\"PNKP is a dual-function enzyme involved in single-strand break repair and nonhomologous end joining.\",\"Mutant, polyQ-expanded ATXN3 inhibits PNKP activity, leading to the accumulation of DNA damage.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Wild-type Ataxin-3 promotes error-free DNA repair and maintains genome stability, whereas the mutant form compromises this function\",\"year\":2015},{\"paper_title\":\"Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3\",\"year\":2015},{\"paper_title\":\"Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription\",\"year\":2019}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"MDC1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"As a deubiquitinase, ATXN3 directly counteracts the polyubiquitination of Mediator Of DNA Damage Checkpoint 1 (MDC1), prolonging its presence on chromatin and ensuring proper DNA damage response activation.\",\"functions\":[{\"function\":\"DNA Damage Response Signaling\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"In the early phase of the DNA double-strand break (DSB) response, ATXN3 acts as a deubiquitinase for the checkpoint mediator MDC1. It counteracts the activity of the SUMO-targeted ubiquitin ligase RNF4, which promotes MDC1's removal from chromatin.\",\"biological_consequence\":[\"ATXN3 counteracts RNF4-mediated MDC1 ubiquitination → Increased MDC1 residence time at DSBs → Efficient recruitment of downstream factors (RNF8, RNF168, BRCA1, 53BP1) → Robust DNA repair signaling.\"],\"specific_effects\":[\"Loss of ATXN3 reduces the chromatin dwell time of MDC1 at DSBs.\",\"ATXN3 is required for efficient MDC1-dependent DSB repair by both non-homologous end-joining and homologous recombination.\",\"ATXN3 is recruited to DSBs in a SUMOylation-dependent manner.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4\",\"year\":2017},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"CHEK1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with Checkpoint Kinase 1 (CHEK1) and prevents its polyubiquitination and subsequent degradation, which is important for facilitating DNA damage checkpoints and repair.\",\"functions\":[{\"function\":\"DNA Damage Checkpoint Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with the checkpoint kinase Chk1 and protects it from polyubiquitination and subsequent proteasomal degradation mediated by E3 ligases like DDB1/CUL4A and FBXO6/CUL1.\",\"biological_consequence\":[\"ATXN3 deubiquitinates CHEK1 → CHEK1 protein stabilization → Maintenance of CHEK1 levels → Proper G2/M checkpoint arrest upon DNA damage → Genome integrity.\"],\"specific_effects\":[\"ATXN3 deficiency leads to a pronounced reduction of Chk1 levels and compromises the G2/M checkpoint.\",\"Under prolonged replication stress, Chk1 is phosphorylated and dissociates from ATXN3, allowing for its degradation and checkpoint termination.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 promotes genome integrity by stabilizing Chk1\",\"year\":2017},{\"paper_title\":\"Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint\",\"year\":2000}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"BECN1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly deubiquitinates Beclin 1 (BECN1), a key protein in autophagy, leading to its stabilization and the stimulation of the autophagic process.\",\"functions\":[{\"function\":\"Autophagy Initiation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with Beclin 1 (BECN1), a key component of the class III PI3K complex essential for autophagy initiation. ATXN3 deubiquitinates BECN1, protecting it from proteasomal degradation.\",\"biological_consequence\":[\"ATXN3 deubiquitinates BECN1 → BECN1 protein stabilization → Increased autophagosome formation → Enhanced autophagic clearance.\"],\"specific_effects\":[\"Depletion of ATXN3 results in reduced BECN1 levels and decreased autophagic flux.\",\"The interaction is mediated by the polyQ tract of ATXN3 and the evolutionarily conserved domain of BECN1.\",\"PolyQ expansion in ATXN3 decreases its deubiquitinase activity towards BECN1, leading to BECN1 destabilization and impaired autophagy.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Polyglutamine tracts regulate beclin 1-dependent autophagy\",\"year\":2017},{\"paper_title\":\"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease\",\"year\":2012},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]},{\"function\":\"Apoptosis/Autophagy Checkpoint\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"BECN1 is a key protein that integrates apoptosis and autophagy signaling, partly through its inhibitory interaction with the anti-apoptotic protein Bcl-2 at the endoplasmic reticulum.\",\"biological_consequence\":[\"ATXN3 stabilizes BECN1 → Increased BECN1 protein pool → Modulates the equilibrium of the BECN1-Bcl-2 complex → Influences the switch between autophagy and apoptosis\"],\"specific_effects\":[\"The interaction between Bcl-2 and BECN1 inhibits autophagy.\",\"Disruption of the Bcl-2/BECN1 complex is a key step in autophagy induction.\",\"Caspase-mediated cleavage of BECN1 can generate fragments that promote apoptosis.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch\",\"year\":2013},{\"paper_title\":\"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy\",\"year\":2005}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"YAP1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 functions as a deubiquitinase for Yes-associated protein 1 (YAP1), removing polyubiquitin chains to protect it from degradation and thereby promoting its oncogenic activity.\",\"functions\":[{\"function\":\"YAP1 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with, deubiquitinates, and stabilizes the Hippo pathway effector YAP1. By removing K48-linked polyubiquitin chains, ATXN3 prevents the proteasomal degradation of YAP1.\",\"biological_consequence\":[\"ATXN3 deubiquitinates YAP1 → Reduced YAP1 degradation → Increased YAP1 protein levels → Enhanced nuclear translocation and transcriptional activity → Upregulation of target genes (CTGF, CYR61) → Promotion of cancer cell proliferation and migration\"],\"specific_effects\":[\"ATXN3 depletion decreases YAP1 protein levels and the expression of YAP/TEAD target genes.\",\"The Josephin domain of ATXN3 interacts with the WW domain of YAP.\",\"ATXN3 specifically inhibits K48-linked polyubiquitination of YAP1.\",\"The interaction and subsequent stabilization of YAP1 by ATXN3 is observed in multiple cancer types, including breast, pancreatic, and prostate cancer.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3 deubiquitinates YAP1 to promote tumor growth\",\"year\":2021},{\"paper_title\":\"ATXN3 promotes prostate cancer progression by stabilizing YAP\",\"year\":2023},{\"paper_title\":\"The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"HDAC3\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 cooperates with and directly regulates the ubiquitination state of Histone Deacetylase 3 (HDAC3), implicating it in transcriptional regulation and immune responses.\",\"functions\":[{\"function\":\"HDAC3 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with and deubiquitinates Histone Deacetylase 3 (HDAC3), protecting it from proteasomal degradation.\",\"biological_consequence\":[\"ATXN3 deubiquitinates HDAC3 → Increased HDAC3 protein stability → Enhanced IFN-I signaling pathway → Potentiated antiviral response\"],\"specific_effects\":[\"ATXN3 deubiquitinates both K48- and K63-linked ubiquitin chains on HDAC3.\",\"The interaction between ATXN3 and HDAC3 increases during viral infection.\",\"Overexpression of ATXN3 upregulates HDAC3 protein levels, while ATXN3 knockout down-regulates them.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3\",\"year\":2018},{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]},{\"function\":\"Transcriptional Repression\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"Wild-type ATXN3 recruits HDAC3 to specific gene promoters, such as the MMP-2 promoter, leading to histone deacetylation and transcriptional repression.\",\"biological_consequence\":[\"ATXN3 binds target promoter → Recruits HDAC3/NCoR complex → Histone deacetylation at promoter → Chromatin condensation → Repression of gene transcription (e.g., MMP-2)\"],\"specific_effects\":[\"Normal ATXN3 cooperates with HDAC3 to repress transcription, a function requiring its ubiquitin-interacting motifs (UIMs).\",\"PolyQ-expanded ATXN3 fails to properly recruit HDAC3, leading to a loss of repressor function and aberrant gene expression.\",\"ATXN3 and HDAC3 cooperate to regulate chromatin organization, a function that is independent of ATXN3's catalytic activity.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation\",\"year\":2008},{\"paper_title\":\"Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways\",\"year\":2018},{\"paper_title\":\"ATXN3 controls DNA replication and transcription by regulating chromatin structure\",\"year\":2023}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"CREBBP\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 is known to interact and cooperate with the transcriptional co-activator CREB-binding protein (CREBBP or CBP), suggesting a direct role in transcriptional regulation.\",\"functions\":[{\"function\":\"CREBBP/p300 Histone Acetyltransferase (HAT) Activity\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with the transcriptional co-activators CREBBP (CBP) and EP300 (p300), which possess histone acetyltransferase (HAT) activity.\",\"biological_consequence\":[\"ATXN3 binds to CREBBP/p300 → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression\"],\"specific_effects\":[\"The C-terminal domain of ATXN3 binds to CREBBP and p300.\",\"ATXN3 is known to cooperate with numerous transcriptional regulators including CBP and p300 to control transcription.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation\",\"year\":2008},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024},{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"EP300\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with the transcriptional co-activator p300 (EP300), indicating its involvement in the regulation of gene expression through chromatin modification.\",\"functions\":[{\"function\":\"CREBBP/p300 Histone Acetyltransferase (HAT) Activity\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with the transcriptional co-activators EP300 (p300) and CREBBP (CBP), which possess histone acetyltransferase (HAT) activity.\",\"biological_consequence\":[\"ATXN3 binds to EP300/CREBBP → Inhibits HAT activity → Reduced histone acetylation at target promoters → Transcriptional repression\"],\"specific_effects\":[\"The C-terminal domain of ATXN3 binds to p300 and CREBBP.\",\"ATXN3 is part of a network of transcriptional regulators that includes p300 and CBP.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation\",\"year\":2008},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024},{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"KEAP1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 regulates the stability of Kelch-like ECH-associated protein 1 (KEAP1) by slowing its proteasomal degradation, suggesting a direct deubiquitinase-substrate relationship.\",\"functions\":[{\"function\":\"KEAP1 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 regulates the turnover of KEAP1, a substrate adaptor for the CUL3 E3 ubiquitin ligase complex that targets NRF2 for degradation.\",\"biological_consequence\":[\"ATXN3 stabilizes KEAP1 → Maintained KEAP1 levels → Constitutive ubiquitination and degradation of NRF2 → Repression of antioxidant gene expression\"],\"specific_effects\":[\"Depletion of ATXN3 leads to destabilization and a decreased half-life of the KEAP1 protein.\",\"Loss of ATXN3 and the subsequent decrease in KEAP1 levels result in an increase of NRF2 and p62/SQSTM1.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina\",\"year\":2021}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"BCL2\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly regulates the autophagy inhibitor B-cell lymphoma 2 (BCL2) by modulating the E3 ligase activity of Parkin, which in turn ubiquitinates BCL2.\",\"functions\":[{\"function\":\"BCL2 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 modulates the E3 ligase activity of Parkin (PARK2). Functional PARK2 directly interacts with and mono-ubiquitinates the anti-apoptotic and autophagy-inhibitory protein BCL2.\",\"biological_consequence\":[\"ATXN3 regulates PARK2 activity → PARK2 mono-ubiquitinates BCL2 → Increased BCL2 protein stability → Enhanced inhibition of autophagy and apoptosis\"],\"specific_effects\":[\"PARK2 directly binds to BCL2 and mediates its mono-ubiquitination.\",\"The mono-ubiquitination of BCL2 by PARK2 increases its protein level.\",\"By stabilizing BCL2, PARK2 enhances the interaction between BCL2 and the autophagy initiator Beclin 1, thereby inhibiting autophagy.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy\",\"year\":2010},{\"paper_title\":\"Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme\",\"year\":2012}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"SOD2\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly regulates the expression of Superoxide Dismutase 2 (SOD2) by modulating the activity of the transcription factor FOXO4, which controls the antioxidant stress response.\",\"functions\":[{\"function\":\"SOD2 Gene Transcription\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 functions as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, both ATXN3 and FOXO4 translocate to the nucleus, where they coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.\",\"biological_consequence\":[\"Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-activation of SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced scavenging of mitochondrial reactive oxygen species (ROS)\"],\"specific_effects\":[\"The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.\",\"Knockdown of ATXN3 represses the expression of SOD2.\",\"Mutant ATXN3 has a reduced capacity to activate FOXO4-mediated SOD2 expression.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3\",\"year\":2011},{\"paper_title\":\"Redox regulation of FoxO transcription factors\",\"year\":2015}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"BAX\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly upregulates the mRNA expression of the pro-apoptotic protein BAX by enhancing the transcriptional activity of p53, which it directly stabilizes.\",\"functions\":[{\"function\":\"Apoptosis\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 indirectly promotes the expression of the pro-apoptotic protein BAX. This occurs through the direct stabilization and activation of the transcription factor p53, which in turn transcriptionally upregulates its target gene, BAX.\",\"biological_consequence\":[\"ATXN3 stabilizes TP53 -> Increased TP53 transcriptional activity -> Upregulation of BAX mRNA expression -> Increased BAX protein levels -> Promotion of apoptosis\"],\"specific_effects\":[\"p53 promotes neuronal apoptosis by enhancing the transcription of proapoptotic genes including Bax.\",\"Mutant ATXN3 increases p53 stability, leading to increased p53-dependent apoptosis.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Tissue-specific vulnerability to apoptosis in Machado-Joseph disease\",\"year\":2023},{\"paper_title\":\"Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons\",\"year\":2010}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"FOXO4\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with the transcription factor FOXO4, and upon oxidative stress, they translocate to the nucleus together to activate the transcription of the SOD2 gene.\",\"functions\":[{\"function\":\"Antioxidant Gene Transcription\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"Under conditions of oxidative stress, ATXN3 interacts with the transcription factor FOXO4. Both proteins translocate to the nucleus and coordinately bind to the promoter of the Superoxide Dismutase 2 (SOD2) gene.\",\"biological_consequence\":[\"Oxidative stress → ATXN3 and FOXO4 translocate to nucleus → Co-binding to SOD2 promoter → Increased SOD2 mRNA and protein expression → Enhanced clearance of ROS → Cellular protection\"],\"specific_effects\":[\"The ATXN3-FOXO4 complex directly stimulates SOD2 gene transcription.\",\"Knockdown of ATXN3 represses the expression of SOD2.\",\"Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression and interferes with FOXO4 binding to the SOD2 promoter.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3\",\"year\":2011},{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024},{\"paper_title\":\"Redox regulation of FoxO transcription factors\",\"year\":2015}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"NRF2\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 is thought to deubiquitinate and stabilize the transcription factor NRF2 (NFE2L2), a master regulator of the antioxidant response, which is a function analogous to other deubiquitinases like DUB3.\",\"functions\":[{\"function\":\"Antioxidant Response Activation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 is proposed to regulate the NRF2 pathway, which controls the expression of antioxidant and detoxification enzymes. This likely occurs through the deubiquitination and stabilization of NRF2, preventing its KEAP1-mediated degradation.\",\"biological_consequence\":[\"ATXN3 deubiquitinates NRF2 → NRF2 escapes KEAP1-mediated degradation → NRF2 accumulates and translocates to nucleus → Binds to ARE sequences → Transcription of antioxidant genes (e.g., HO-1, NQO1)\"],\"specific_effects\":[\"NRF2 is a master regulator of the antioxidant response, and its stability is tightly controlled by KEAP1-mediated ubiquitination.\",\"Activation of the NRF2 pathway is a key cellular defense against oxidative stress.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The complexity of the Nrf2 pathway: Beyond the antioxidant response\",\"year\":2015},{\"paper_title\":\"The effect of ATX through Nrf2 pathway on different disorders.\",\"year\":2023},{\"paper_title\":\"Activation of NRF2 and FXN in Friedreich Ataxia\",\"year\":2023}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"TRAF6\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 is known to deubiquitinate TNF receptor-associated factor 6 (TRAF6), thereby modulating immune signaling pathways.\",\"functions\":[{\"function\":\"NF-κB and MAPK Signaling\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 acts as a deubiquitinase for TRAF6, an E3 ubiquitin ligase crucial for activating downstream signaling pathways like NF-κB and MAPK upon stimulation of receptors such as TLRs and TNFRs.\",\"biological_consequence\":[\"ATXN3 deubiquitinates TRAF6 → Reduced TRAF6-mediated signaling → Decreased activation of IKK complex and MAPKs → Attenuated NF-κB and AP-1 activation → Downregulation of inflammatory gene expression\"],\"specific_effects\":[],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion\",\"year\":2023}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"LC3\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 contains conserved LIR domains that directly interact with the autophagy adaptors LC3C and GABARAP, localizing to early autophagosomes in a transient regulatory interaction.\",\"functions\":[{\"function\":\"Autophagosome Association\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 contains LC3-interacting region (LIR) motifs that allow it to directly bind to members of the Atg8 protein family, such as LC3 and GABARAP, which are localized on autophagosomal membranes.\",\"biological_consequence\":[\"ATXN3 binds to LC3/GABARAP via LIR motif → Recruitment of ATXN3 to autophagosome membrane → Modulation of local ubiquitination events → Regulation of autophagic flux\"],\"specific_effects\":[\"LIR motifs are short linear sequences that mediate binding to Atg8-family proteins.\",\"Proteins containing LIR motifs are recruited to LC3/GABARAP through hydrophobic interactions.\",\"UIM-containing proteins, including ATXN3, have been shown to interact with both LC3 and GABARAP subfamilies.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Semisynthetic LC3 Probes for Autophagy Pathways Reveal a Noncanonical LC3 Interacting Region Motif Crucial for the Enzymatic Activity of Human ATG3\",\"year\":2020},{\"paper_title\":\"The rapidly expanding role of LC3-interacting regions in autophagy\",\"year\":2024},{\"paper_title\":\"Atg8-Family Proteins—Structural Features and Molecular Interactions in Autophagy and Beyond\",\"year\":2020}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PML\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with the Promyelocytic leukemia (PML) protein, and expression of mutant ATXN3 alters the normal nuclear distribution of PML.\",\"functions\":[{\"function\":\"PML Nuclear Body Organization\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with the Promyelocytic leukemia (PML) protein, a key component of PML nuclear bodies, which are subnuclear structures involved in various cellular processes like transcription, DNA repair, and apoptosis.\",\"biological_consequence\":[\"Mutant ATXN3 interacts with PML → Sequestration or mislocalization of PML protein → Disruption of PML nuclear body integrity → Impaired PML-dependent cellular functions\"],\"specific_effects\":[\"Expression of certain PML isoforms (e.g., PML IV) can promote the degradation of soluble polyQ proteins, a protective mechanism that is disrupted when PML is mislocalized. [4]\",\"The sequestration of PML by mutant ATXN3 can impair the DNA damage response (DDR) and other PML-NB-associated functions. [7]\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins\",\"year\":2007}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"SP1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 can act as a transcriptional co-repressor by interacting with the transcription factor SP1.\",\"functions\":[{\"function\":\"Transcriptional Repression\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 is known to interact with the transcription factor SP1, acting as a co-repressor to regulate gene expression.\",\"biological_consequence\":[\"ATXN3 binds SP1 on chromatin -> Recruitment of repressor complexes -> Transcriptional silencing\"],\"specific_effects\":[\"Normal ATXN3 binds to the promoter of the MMP-2 gene and represses its transcription by recruiting a complex containing HDAC3 and NCoR. [9, 10]\",\"PolyQ-expanded ATXN3 loses this repressor function, leading to aberrant MMP-2 transcription. [9, 19]\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation\",\"year\":2008}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"HSP70\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with Heat Shock Protein 70 (HSP70), specifically Hsc70-4 in Drosophila, via its UIMs, which enhances aggregation and toxicity.\",\"functions\":[{\"function\":\"ATXN3 Aggregation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly interacts with Heat Shock Protein 70 (HSP70/HSPA) chaperones through its ubiquitin-interacting motifs (UIMs).\",\"biological_consequence\":[\"Misfolded polyQ-ATXN3 binds HSP70 -> Sequestration of chaperones into aggregates -> Impaired protein quality control -> Enhanced aggregation and toxicity\"],\"specific_effects\":[\"HSP70 is a common component of the neuronal intranuclear inclusions found in SCA3.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"HSP40\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"The co-chaperone HSP40 (DNAJ) is recruited to and localizes within the intranuclear inclusions formed by mutant ATXN3, working alongside HSP70.\",\"functions\":[{\"function\":\"ATXN3 Aggregation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"The co-chaperone HSP40 (DNAJ family) is recruited to and co-localizes with aggregates formed by polyQ-expanded ATXN3, working in concert with HSP70.\",\"biological_consequence\":[\"Misfolded polyQ-ATXN3 recruits HSP40/HSP70 complex -> Sequestration of chaperone machinery -> Formation of stable intranuclear inclusions -> Cellular toxicity\"],\"specific_effects\":[\"HSP40 is found within the neuronal intranuclear inclusions characteristic of SCA3.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"UBQLN1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"Ubiquilin-1 (UBQLN1) is reported to interact with ATXN3 and is involved in protein degradation pathways and aggresome formation.\",\"functions\":[{\"function\":\"Protein Degradation & Aggresome Formation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with Ubiquilin-1 (UBQLN1), a protein that links the ubiquitination machinery to the proteasome and is also involved in aggresome formation.\",\"biological_consequence\":[\"ATXN3 and UBQLN1 co-recognize ubiquitinated substrates -> Facilitated delivery to proteasome or aggresome pathway -> Clearance of misfolded proteins\"],\"specific_effects\":[\"UBQLN1 is a component of the cellular machinery for clearing aggregation-prone proteins.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"UBQLN2\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"Co-immunoprecipitation studies and analysis of human and mouse brain tissue show that UBQLN2 does not interact with either normal or polyQ-expanded ATXN3. Unlike in Huntington's disease where UBQLN2 is recruited to aggregates, it is absent from ATXN3 inclusions in SCA3.\",\"functions\":[{\"function\":\"Protein Aggregation & Clearance\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"In contrast to other polyglutamine diseases like Huntington's, UBQLN2, a key protein in the ubiquitin-proteasome pathway, does not interact with or co-localize to the protein aggregates formed by polyQ-expanded ATXN3.\",\"biological_consequence\":[\"PolyQ-ATXN3 aggregates form → UBQLN2 is not recruited → ATXN3 aggregates are not processed by UBQLN2-dependent pathways → Highlights a distinct pathomechanism for SCA3 compared to Huntington's disease\"],\"specific_effects\":[\"Co-precipitation studies in cultured cells demonstrated that UBQLN2 fails to interact with normal or expanded ATXN3 protein.\",\"UBQLN2 is recruited to inclusions in Huntington's disease (HD) but not in Spinocerebellar Ataxia Type 3 (SCA3) mouse models and human brain tissue.\",\"The lack of co-localization suggests that components of neuronal protein quality control may be differentially perturbed in distinct polyQ diseases.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3\",\"year\":2015}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PSMC6\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 interacts with proteasome subunits, which are found within the neuronal intranuclear inclusions characteristic of SCA3.\",\"functions\":[{\"function\":\"Proteasomal Degradation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with subunits of the 26S proteasome, such as PSMC6 (Rpt4), a component of the 19S regulatory particle.\",\"biological_consequence\":[\"ATXN3 binds to 19S proteasome cap -> Deubiquitinates substrates prior to degradation -> Regulation of protein turnover\"],\"specific_effects\":[\"Proteasome subunits are often found within the intranuclear inclusions formed by mutant ATXN3.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"DYNC1H1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 acts as an adaptor to link polyubiquitinated substrates to the dynein motor protein complex to facilitate transport to the aggresome.\",\"functions\":[{\"function\":\"Aggresome Formation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 interacts with the dynein motor complex, including the heavy chain DYNC1H1. It acts as an adaptor protein, linking polyubiquitinated protein aggregates to the dynein machinery.\",\"biological_consequence\":[\"ATXN3 binds ubiquitinated aggregate -> ATXN3 binds DYNC1H1 -> Dynein motor transports aggregate along microtubule -> Delivery to perinuclear aggresome\"],\"specific_effects\":[\"This transport mechanism is dependent on both ATXN3 and HDAC6.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation\",\"year\":2011}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"HMOX1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly upregulates the expression of Heme Oxygenase 1 (HMOX1) by deubiquitinating and stabilizing the transcription factor NRF2, which then activates HMOX1 transcription.\",\"functions\":[{\"function\":\"HMOX1 Gene Transcription\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 is proposed to deubiquitinate and stabilize the transcription factor NRF2. This stabilization allows NRF2 to accumulate and translocate to the nucleus, where it binds to the Antioxidant Response Element (ARE) located in the promoter of the Heme Oxygenase 1 (HMOX1) gene.\",\"biological_consequence\":[\"ATXN3 stabilizes NRF2 → NRF2 accumulates in the nucleus → NRF2 binds to the ARE in the HMOX1 promoter → Increased HMOX1 mRNA and protein expression → Heme degradation and production of antioxidant biliverdin/bilirubin\"],\"specific_effects\":[\"HMOX1 is a well-established target gene of the NRF2 transcription factor.\",\"NRF2 activation is a prerequisite for HMOX1 induction in response to oxidative stress.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1\",\"year\":2008},{\"paper_title\":\"Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism\",\"year\":2015}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"GCLM\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly enhances the expression of Glutamate-Cysteine Ligase Modifier Subunit (GCLM) by stabilizing its transcriptional activator, NRF2.\",\"functions\":[{\"function\":\"GCLM Gene Transcription & Glutathione Synthesis\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 is thought to stabilize the transcription factor NRF2, promoting its nuclear translocation and activity. NRF2 then directly binds to the Antioxidant Response Element (ARE) in the promoter of the Glutamate-Cysteine Ligase Modifier Subunit (GCLM) gene, activating its transcription.\",\"biological_consequence\":[\"ATXN3 stabilizes NRF2 → NRF2 activates GCLM transcription → Increased GCLM protein levels → Enhanced GCL enzyme activity → Increased synthesis of glutathione (GSH) → Improved cellular detoxification and antioxidant capacity\"],\"specific_effects\":[\"NRF2 governs the basal and inducible expression of both GCLC and GCLM subunits of glutamate-cysteine ligase.\",\"A decline in NRF2 transcriptional activity is linked to an age-related loss of glutathione synthesis.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid\",\"year\":2004},{\"paper_title\":\"Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo\",\"year\":2008}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"SQSTM1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3, playing a role in the formation of aggresomes and protecting cells from cell death.\",\"functions\":[{\"function\":\"Aggresome Formation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"The selective autophagy receptor p62/SQSTM1 directly interacts with polyQ-expanded ATXN3. This interaction is crucial for the sequestration of misfolded ATXN3 into larger inclusion bodies.\",\"biological_consequence\":[\"PolyQ-ATXN3 aggregates form -> SQSTM1 binds to aggregates -> Facilitates coalescence into a single aggresome -> Sequestration of toxic protein -> Cellular protection\"],\"specific_effects\":[\"p62 directly interacts with pathogenic ataxin-3 but not normal ataxin-3.\",\"The interaction is dependent on microtubules.\",\"p62 protects cells against polyQ-expanded ataxin-3-induced cell death.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"p62/sequestosome 1 regulates aggresome formation of pathogenic ataxin-3 with expanded polyglutamine\",\"year\":2014},{\"paper_title\":\"p62, the Receptor for Selective Autophagy, Contributes in ATXN3 Aggregate Formation in Spinocerebellar Ataxia Type 3\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"SUMO1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 is covalently modified by Small Ubiquitin-like Modifier 1 (SUMO-1), a process known as SUMOylation. This direct interaction was identified by yeast two-hybrid and confirmed by co-immunoprecipitation, and it is thought to regulate the biological function of ATXN3.\",\"functions\":[{\"function\":\"ATXN3 SUMOylation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 is post-translationally modified by covalent attachment of Small Ubiquitin-like Modifier 1 (SUMO-1). This process, known as SUMOylation, is catalyzed by a cascade of E1, E2 (UBC9), and E3 (e.g., PIAS1) enzymes.\",\"biological_consequence\":[\"SUMO1 is conjugated to ATXN3 -> Prevents ubiquitin chain attachment -> Reduced proteasomal degradation -> Increased ATXN3 protein stability\"],\"specific_effects\":[\"SUMO modification at K166 of polyQ-expanded ATXN3 enhances its stability.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"PIAS1 promotes ATXN3 SUMOylation and enhances its protein stability\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PIAS1\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"The SUMO E3 ligase PIAS1 directly interacts with ATXN3 to promote its SUMOylation. This interaction stabilizes ATXN3 by preventing its proteasome-mediated degradation.\",\"functions\":[{\"function\":\"ATXN3 SUMOylation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"The SUMO E3 ligase PIAS1 directly interacts with ATXN3 and promotes its conjugation with SUMO proteins.\",\"biological_consequence\":[\"PIAS1 binds ATXN3 -> Catalyzes SUMO attachment -> Reduced ATXN3 ubiquitination -> Increased ATXN3 protein levels\"],\"specific_effects\":[\"PIAS1 knockdown leads to a dose-dependent decrease in both wild-type and mutant ATXN3 protein levels.\",\"The stabilization of ATXN3 by PIAS1 is prevented by treatment with the proteasome inhibitor MG132.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"PIAS1 S510G variant acts as a genetic modifier of spinocerebellar ataxia type 3 by selectively impairing mutant ataxin-3 proteostasis\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"UBC9\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"As the primary E2 SUMO-conjugating enzyme, UBC9 is a necessary and direct interactor for the SUMOylation of ATXN3, working in concert with E3 ligases like PIAS1.\",\"functions\":[{\"function\":\"ATXN3 SUMOylation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"UBC9 is the essential E2 SUMO-conjugating enzyme that directly interacts with ATXN3 and transfers the activated SUMO moiety to it, a process facilitated by an E3 ligase like PIAS1.\",\"biological_consequence\":[\"Activated SUMO is transferred to UBC9 -> UBC9/PIAS1/ATXN3 form a complex -> SUMO is covalently attached to ATXN3 -> ATXN3 stability is enhanced\"],\"specific_effects\":[\"The SUMOylation pathway involves the sequential action of E1, E2 (UBC9), and E3 enzymes.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Conserved residues within PIAS1 and UBC9 play a key role in the...\",\"year\":2024}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"SRSF7\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly interacts with and deubiquitinates the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), thereby regulating its stability and influencing mRNA splicing processes, including that of the MAPT (Tau) gene.\",\"functions\":[{\"function\":\"mRNA Splicing\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 functions as a deubiquitinase for the Arginine/Serine-Rich Splicing Factor 7 (SRSF7), removing polyubiquitin chains to regulate its stability and activity.\",\"biological_consequence\":[\"ATXN3 deubiquitinates SRSF7 -> SRSF7 is stabilized -> Altered alternative splicing of target genes (e.g., MAPT) -> Changes in protein isoform ratios\"],\"specific_effects\":[\"Loss of ATXN3 leads to altered polyubiquitylation of multiple proteins involved in RNA metabolism.\",\"Loss of ATXN3 deregulates MAPT exon 10 splicing.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors\",\"year\":2019}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"TUBB\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 directly binds to tubulin with high affinity (around 50nM). This interaction is crucial for the microtubule-dependent transport of protein aggregates to the aggresome.\",\"functions\":[{\"function\":\"Microtubule-Dependent Aggregate Transport\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 directly binds to tubulin, the main component of microtubules, with high affinity.\",\"biological_consequence\":[\"ATXN3 binds aggregate -> ATXN3 binds tubulin/microtubules -> Aggregate is trafficked along microtubule network -> Sequestration in the aggresome\"],\"specific_effects\":[],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The polyglutamine neurodegenerative protein Ataxin 3 regulates aggresome formation\",\"year\":2011}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"KLF4\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 functions as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), indicating a direct enzyme-substrate interaction that regulates KLF4 stability.\",\"functions\":[{\"function\":\"KLF4 Protein Stability\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 acts as a deubiquitinase for the transcription factor Krüppel-like factor 4 (KLF4), directly binding to it and removing polyubiquitin chains.\",\"biological_consequence\":[\"ATXN3 deubiquitinates KLF4 -> KLF4 protein is stabilized -> Increased KLF4 levels -> Promotion of breast cancer metastasis\"],\"specific_effects\":[\"ATXN3 was identified as a KLF4 deubiquitinase from a screen of 65 DUBs.\",\"High expression of both ATXN3 and KLF4 is associated with a poor prognosis in breast cancer patients.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4\",\"year\":2019}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PJA1\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"The E3 ubiquitin ligase PJA1 (also known as RING finger protein 127) directly interacts with ATXN3 to promote its ubiquitination and subsequent degradation by both the proteasome and autophagy.\",\"functions\":[{\"function\":\"ATXN3 Protein Stability\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"The E3 ubiquitin ligase PJA1 (Praja1) interacts with and ubiquitinates ATXN3, targeting it for degradation.\",\"biological_consequence\":[\"PJA1 ubiquitinates ATXN3 -> ATXN3 is targeted for degradation -> Reduced ATXN3 protein levels and aggregation -> Suppression of polyQ toxicity\"],\"specific_effects\":[\"PJA1 expression is diminished when polyQ-expanded proteins are expressed.\",\"PJA1 promotes ATXN3 degradation by both the proteasome and autophagy.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity\",\"year\":2018}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"AMFR\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"The E3 ubiquitin ligase AMFR (also known as Gp78) directly polyubiquitinates ATXN3, targeting it for degradation through the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway.\",\"functions\":[{\"function\":\"ATXN3 Protein Stability\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"The E3 ubiquitin ligase AMFR (gp78), an enzyme involved in Endoplasmic Reticulum-Associated Degradation (ERAD), directly interacts with and polyubiquitinates ATXN3.\",\"biological_consequence\":[\"AMFR ubiquitinates ATXN3 -> ATXN3 is targeted to the ERAD pathway -> Proteasomal degradation of ATXN3\"],\"specific_effects\":[\"Overexpression of gp78 promotes the ubiquitination and degradation of ATXN3.\",\"Knockdown of gp78 stabilizes ATXN3 protein.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation\",\"year\":2009}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"CAMK2A\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"Proteomic analysis of ATXN3 pull-downs from mouse brain tissue revealed that mutant ATXN3 abnormally interacts with Calcium/calmodulin-dependent protein kinase II subunit alpha (Camk2a), a component of large protein complexes.\",\"functions\":[{\"function\":\"Protein Complex Formation\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"Proteomic analysis of brain lysates from a SCA3 mouse model revealed that mutant, polyQ-expanded ATXN3 abnormally interacts with Camk2a, a subunit of the Calcium/calmodulin-dependent protein kinase II complex.\",\"biological_consequence\":[\"Mutant ATXN3 binds CAMK2A -> Sequestration into large protein complexes/aggregates -> Disruption of normal CAMK2A function (e.g., synaptic plasticity, transport)\"],\"specific_effects\":[\"Mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5, Cct6, Tcp1, Camk2a and Camk2b.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model\",\"year\":2023}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"PTEN\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 is suggested to directly regulate the tumor suppressor PTEN, with evidence pointing to a deubiquitinase-substrate relationship that inhibits PTEN's anti-oncogene function in certain cancers.\",\"functions\":[{\"function\":\"PTEN Transcription\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 acts as a transcriptional repressor of the tumor suppressor gene PTEN. This regulation is independent of ATXN3's deubiquitinase activity on the PTEN protein itself.\",\"biological_consequence\":[\"ATXN3 represses PTEN promoter -> Decreased PTEN mRNA and protein -> Reduced antagonism of PI3K pathway -> Increased Akt phosphorylation and signaling\"],\"specific_effects\":[\"Depletion of ATXN3 increases PTEN transcript abundance but does not alter PTEN protein stability.\",\"ATXN3 depletion is sufficient to downregulate Akt phosphorylation.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells\",\"year\":2014},{\"paper_title\":\"The equilibrium of tumor suppression: DUBs as active regulators of PTEN\",\"year\":2022}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"MBNL1\",\"direction\":\"bidirectional\",\"arrow\":\"inhibits\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly affects the splicing factor Muscleblind-like Splicing Regulator 1 (MBNL1). The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms hairpin structures that sequester MBNL1 into nuclear foci, leading to its functional inactivation and subsequent misregulation of alternative splicing.\",\"functions\":[{\"function\":\"MBNL1 Splicing Activity\",\"arrow\":\"inhibits\",\"interaction_effect\":\"inhibits\",\"interaction_direction\":\"\",\"cellular_process\":\"The expanded CAG-repeat RNA transcribed from the mutant ATXN3 gene forms toxic hairpin structures in the nucleus. These RNA structures act as a scaffold to sequester the Muscleblind-like Splicing Regulator 1 (MBNL1).\",\"biological_consequence\":[\"Mutant ATXN3 gene is transcribed into toxic RNA -> RNA hairpins sequester MBNL1 into nuclear foci -> MBNL1 is functionally depleted -> Misregulation of alternative splicing -> Cellular dysfunction\"],\"specific_effects\":[\"The sequestration of MBNL1 into nuclear RNA foci by expanded CAG repeats is a shared pathomechanism with myotonic dystrophy type 1. [3, 28]\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies\",\"year\":2015}]}]}",
    "{\"main\":\"ATXN3\",\"primary\":\"MAPT\",\"direction\":\"bidirectional\",\"arrow\":\"activates\",\"intent\":\"regulation\",\"support_summary\":\"ATXN3 indirectly regulates the alternative splicing of Microtubule-Associated Protein Tau (MAPT) by controlling the stability of the splicing factor SRSF7.\",\"functions\":[{\"function\":\"MAPT (Tau) Alternative Splicing\",\"arrow\":\"activates\",\"interaction_effect\":\"activates\",\"interaction_direction\":\"\",\"cellular_process\":\"ATXN3 deubiquitinates and stabilizes the splicing factor SRSF7. SRSF7 is a key regulator of MAPT (Tau) exon 10 splicing, which determines the ratio of 4-repeat (4R) to 3-repeat (3R) Tau isoforms.\",\"biological_consequence\":[\"ATXN3 stabilizes SRSF7 → Proper regulation of MAPT exon 10 splicing → Maintained 4R/3R-Tau ratio → Normal neuronal function\"],\"specific_effects\":[\"Loss of ATXN3 function leads to a decreased 4R/3R-Tau ratio.\",\"Similar splicing alterations are observed in cellular models of SCA3 and in patient brains.\"],\"pmids\":[],\"confidence\":null,\"evidence\":[{\"paper_title\":\"Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors\",\"year\":2019}]}]}"
  ],
  "step_json": {
    "step": "step3_snapshot",
    "rows": 46
  }
}